Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 4th edition, 372 pages

+ the daily Top 10

  Breast Cancer

  Free Subscription

Articles published in PLoS One

Retrieve available abstracts of 578 articles:
HTML format

Single Articles

    January 2020
  1. JAMSHIDII N, Chang J, Mock K, Nguyen B, et al
    Evaluation of the predictive ability of ultrasound-based assessment of breast cancer using BI-RADS natural language reporting against commercial transcriptome-based tests.
    PLoS One. 2020;15:e0226634.
    PubMed     Abstract available

  2. PERRIER A, Boelle PY, Chretien Y, Gligorov J, et al
    An updated evaluation of serum sHER2, CA15.3, and CEA levels as biomarkers for the response of patients with metastatic breast cancer to trastuzumab-based therapies.
    PLoS One. 2020;15:e0227356.
    PubMed     Abstract available

  3. WANG Q, Liu X, Ren S
    Tofu intake is inversely associated with risk of breast cancer: A meta-analysis of observational studies.
    PLoS One. 2020;15:e0226745.
    PubMed     Abstract available

  4. GRESNER P, Jablonska E, Gromadzinska J
    Rad51 paralogs and the risk of unselected breast cancer: A case-control study.
    PLoS One. 2020;15:e0226976.
    PubMed     Abstract available

  5. AL-WAJEEH AS, Salhimi SM, Al-Mansoub MA, Khalid IA, et al
    Comparative proteomic analysis of different stages of breast cancer tissues using ultra high performance liquid chromatography tandem mass spectrometer.
    PLoS One. 2020;15:e0227404.
    PubMed     Abstract available

  6. SHAMSI U, Khan S, Azam I, Habib Khan A, et al
    A multicenter case control study of association of vitamin D with breast cancer among women in Karachi, Pakistan.
    PLoS One. 2020;15:e0225402.
    PubMed     Abstract available

  7. ROJAS L, Muniz S, Medina L, Pena J, et al
    Cost-minimization analysis of subcutaneous versus intravenous trastuzumab administration in Chilean patients with HER2-positive early breast cancer.
    PLoS One. 2020;15:e0227961.
    PubMed     Abstract available

  8. FERREIRA LC, Orso F, Dettori D, Lacerda JZ, et al
    The role of melatonin on miRNAs modulation in triple-negative breast cancer cells.
    PLoS One. 2020;15:e0228062.
    PubMed     Abstract available

  9. TFAILY MA, Nassar F, Sellam LS, Amir-Tidadini ZC, et al
    miRNA expression in advanced Algerian breast cancer tissues.
    PLoS One. 2020;15:e0227928.
    PubMed     Abstract available

  10. CHENG HG, Gonzalez-Reymundez A, Li I, Pathak A, et al
    Breast cancer survival and the expression of genes related to alcohol drinking.
    PLoS One. 2020;15:e0228957.
    PubMed     Abstract available

  11. JAMSHIDI N, Chang J, Mock K, Nguyen B, et al
    Correction: Evaluation of the predictive ability of ultrasound-based assessment of breast cancer using BI-RADS natural language reporting against commercial transcriptome-based tests.
    PLoS One. 2020;15:e0229584.
    PubMed     Abstract available

  12. LEE S, Liang X, Woods M, Reiner AS, et al
    Machine learning on genome-wide association studies to predict the risk of radiation-associated contralateral breast cancer in the WECARE Study.
    PLoS One. 2020;15:e0226157.
    PubMed     Abstract available

  13. MU Q, Yu J, Griffin JI, Wu Y, et al
    Novel drug combination nanoparticles exhibit enhanced plasma exposure and dose-responsive effects on eliminating breast cancer lung metastasis.
    PLoS One. 2020;15:e0228557.
    PubMed     Abstract available

  14. LI M, Han M, Chen Z, Tang Y, et al
    Does marital status correlate with the female breast cancer risk? A systematic review and meta-analysis of observational studies.
    PLoS One. 2020;15:e0229899.
    PubMed     Abstract available

  15. RATH M, Li Q, Li H, Lindstrom S, et al
    Correction: Evaluation of significant genome-wide association studies risk-SNPs in young breast cancer patients.
    PLoS One. 2020;15:e0230529.
    PubMed     Abstract available

  16. AN YY, Kim SH, Kang BJ, Suh YJ, et al
    Feasibility of abbreviated magnetic resonance imaging (AB-MRI) screening in women with a personal history (PH) of breast cancer.
    PLoS One. 2020;15:e0230347.
    PubMed     Abstract available

  17. KUSI G, Boamah Mensah AB, Boamah Mensah K, Dzomeku VM, et al
    Caregiving motivations and experiences among family caregivers of patients living with advanced breast cancer in Ghana.
    PLoS One. 2020;15:e0229683.
    PubMed     Abstract available

  18. VILLARREAL-GARZA C, Lopez-Martinez EA, Deneken-Hernandez Z, Maffuz-Aziz A, et al
    Change in therapeutic management after the EndoPredict assay in a prospective decision impact study of Mexican premenopausal breast cancer patients.
    PLoS One. 2020;15:e0228884.
    PubMed     Abstract available

  19. MIAO LF, Ye XH, He XF
    Individual and combined effects of GSTM1, GSTT1, and GSTP1 polymorphisms on breast cancer risk: A meta-analysis and re-analysis of systematic meta-analyses.
    PLoS One. 2020;15:e0216147.
    PubMed     Abstract available

  20. HE TF, Yost SE, Frankel PH, Dagis A, et al
    Multi-panel immunofluorescence analysis of tumor infiltrating lymphocytes in triple negative breast cancer: Evolution of tumor immune profiles and patient prognosis.
    PLoS One. 2020;15:e0229955.
    PubMed     Abstract available

  21. KIM YS, Sun S, Yoon JS, Ko YH, et al
    Clinical implications of APOBEC3A and 3B expression in patients with breast cancer.
    PLoS One. 2020;15:e0230261.
    PubMed     Abstract available

  22. KALLARACKAL J, Burger F, Bianco S, Romualdi A, et al
    A 3-gene biomarker signature to predict response to taxane-based neoadjuvant chemotherapy in breast cancer.
    PLoS One. 2020;15:e0230313.
    PubMed     Abstract available

  23. Retraction: Chemotherapeutic Potential of 2-[Piperidinoethoxyphenyl]-3-Phenyl-2H-Benzo(b)pyran in Estrogen Receptor- Negative Breast Cancer Cells: Action via Prevention of EGFR Activation and Combined Inhibition of PI-3-K/Akt/FOXO and MEK/Erk/AP-1 Pat
    PLoS One. 2020;15:e0231282.

  24. MARTINO G, Catalano A, Agostino RM, Bellone F, et al
    Quality of life and psychological functioning in postmenopausal women undergoing aromatase inhibitor treatment for early breast cancer.
    PLoS One. 2020;15:e0230681.
    PubMed     Abstract available

  25. LE DU F, Fujii T, Kida K, Davis DW, et al
    EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream(R) in patients with breast cancer treated with primary systemic therapy.
    PLoS One. 2020;15:e0229903.
    PubMed     Abstract available

  26. LEE SB, Bose S, Ahn SH, Son BH, et al
    Breast cancer diagnosis by analysis of serum N-glycans using MALDI-TOF mass spectroscopy.
    PLoS One. 2020;15:e0231004.
    PubMed     Abstract available

  27. SCHNEIDER PP, Pouwels XGLV, Passos VL, Ramaekers BLT, et al
    Variability of cost trajectories over the last year of life in patients with advanced breast cancer in the Netherlands.
    PLoS One. 2020;15:e0230909.
    PubMed     Abstract available

  28. SMEDA M, Kij A, Proniewski B, Matyjaszczyk-Gwarda K, et al
    Unexpected effects of long-term treatment with acetylsalicylic acid on late phase of pulmonary metastasis in murine model of orthotopic breast cancer.
    PLoS One. 2020;15:e0230520.
    PubMed     Abstract available

  29. BEAUCHAMP A, Mohebbi M, Cooper A, Pridmore V, et al
    The impact of translated reminder letters and phone calls on mammography screening booking rates: Two randomised controlled trials.
    PLoS One. 2020;15:e0226610.
    PubMed     Abstract available

  30. TUTZAUER J, Sjostrom M, Bendahl PO, Ryden L, et al
    Plasma membrane expression of G protein-coupled estrogen receptor (GPER)/G protein-coupled receptor 30 (GPR30) is associated with worse outcome in metachronous contralateral breast cancer.
    PLoS One. 2020;15:e0231786.
    PubMed     Abstract available

  31. PALMER ACS, Zortea M, Souza A, Santos V, et al
    Clinical impact of melatonin on breast cancer patients undergoing chemotherapy; effects on cognition, sleep and depressive symptoms: A randomized, double-blind, placebo-controlled trial.
    PLoS One. 2020;15:e0231379.
    PubMed     Abstract available

  32. ZHANG H, Luo M, Liang X, Wang D, et al
    Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer.
    PLoS One. 2020;15:e0232166.
    PubMed     Abstract available

  33. DING Y, Ding K, Qian H, Yu X, et al
    Impact on survival of estrogen receptor, progesterone receptor and Ki-67 expression discordance pre- and post-neoadjuvant chemotherapy in breast cancer.
    PLoS One. 2020;15:e0231895.
    PubMed     Abstract available

  34. KOROLKOVA OY, Widatalla SE, Whalen DS, Nangami GN, et al
    Reciprocal expression of Annexin A6 and RasGRF2 discriminates rapidly growing from invasive triple negative breast cancer subsets.
    PLoS One. 2020;15:e0231711.
    PubMed     Abstract available

  35. PURRINGTON KS, Knight J 3rd, Dyson G, Ali-Fehmi R, et al
    CLCA2 expression is associated with survival among African American women with triple negative breast cancer.
    PLoS One. 2020;15:e0231712.
    PubMed     Abstract available

  36. ADAM A, Koranteng F
    Availability, accessibility, and impact of social support on breast cancer treatment among breast cancer patients in Kumasi, Ghana: A qualitative study.
    PLoS One. 2020;15:e0231691.
    PubMed     Abstract available

  37. HSU PC, Kadlubar SA, Siegel ER, Rogers LJ, et al
    Genome-wide DNA methylation signatures to predict pathologic complete response from combined neoadjuvant chemotherapy with bevacizumab in breast cancer.
    PLoS One. 2020;15:e0230248.
    PubMed     Abstract available

  38. PODUVAL D, Sichmanova Z, Straume AH, Lonning PE, et al
    The novel microRNAs hsa-miR-nov7 and hsa-miR-nov3 are over-expressed in locally advanced breast cancer.
    PLoS One. 2020;15:e0225357.
    PubMed     Abstract available

  39. DOBROSSY B, Girasek E, Susanszky A, Koncz Z, et al
    "Clicks, likes, shares and comments" a systematic review of breast cancer screening discourse in social media.
    PLoS One. 2020;15:e0231422.
    PubMed     Abstract available

  40. WETSTEIN SC, Onken AM, Luffman C, Baker GM, et al
    Deep learning assessment of breast terminal duct lobular unit involution: Towards automated prediction of breast cancer risk.
    PLoS One. 2020;15:e0231653.
    PubMed     Abstract available

  41. EIRIKSSON FF, Nohr MK, Costa M, Bodvarsdottir SK, et al
    Lipidomic study of cell lines reveals differences between breast cancer subtypes.
    PLoS One. 2020;15:e0231289.
    PubMed     Abstract available

  42. PAMPHLETT R, Satgunaseelan L, Kum Jew S, Doble PA, et al
    Elemental bioimaging shows mercury and other toxic metals in normal breast tissue and in breast cancers.
    PLoS One. 2020;15:e0228226.
    PubMed     Abstract available

  43. HUANG BARTLETT C, Mardekian J, Cotter MJ, Huang X, et al
    Concordance of real-world versus conventional progression-free survival from a phase 3 trial of endocrine therapy as first-line treatment for metastatic breast cancer.
    PLoS One. 2020;15:e0227256.
    PubMed     Abstract available

  44. BOZEK A, Jarzab J, Mielnik M, Bogacz A, et al
    Can atopy have a protective effect against cancer?
    PLoS One. 2020;15:e0226950.
    PubMed     Abstract available

  45. ELLMANN S, Wenkel E, Dietzel M, Bielowski C, et al
    Implementation of machine learning into clinical breast MRI: Potential for objective and accurate decision-making in suspicious breast masses.
    PLoS One. 2020;15:e0228446.
    PubMed     Abstract available

  46. ESPINOSA FERNANDEZ JR, Eckhardt BL, Lee J, Lim B, et al
    Identification of triple-negative breast cancer cell lines classified under the same molecular subtype using different molecular characterization techniques: Implications for translational research.
    PLoS One. 2020;15:e0231953.
    PubMed     Abstract available

  47. PAL CHOUDHURY P, Maas P, Wilcox A, Wheeler W, et al
    iCARE: An R package to build, validate and apply absolute risk models.
    PLoS One. 2020;15:e0228198.
    PubMed     Abstract available

  48. LI M, Yue C, Zuo X, Jin G, et al
    The effect of interleukin 10 polymorphisms on breast cancer susceptibility in Han women in Shaanxi Province.
    PLoS One. 2020;15:e0232174.
    PubMed     Abstract available

  49. HADGU E, Seifu D, Tigneh W, Bokretsion Y, et al
    Distribution and characteristics of androgen receptor (AR) in breast cancer among women in Addis Ababa, Ethiopia: A cross sectional study.
    PLoS One. 2020;15:e0232519.
    PubMed     Abstract available

  50. RINALDI J, Sokol ES, Hartmaier RJ, Trabucco SE, et al
    The genomic landscape of metastatic breast cancer: Insights from 11,000 tumors.
    PLoS One. 2020;15:e0231999.
    PubMed     Abstract available

  51. LEE KN, Torres MA, Troeschel AN, He J, et al
    Type 2 diabetes, breast cancer specific and overall mortality: Associations by metformin use and modification by race, body mass, and estrogen receptor status.
    PLoS One. 2020;15:e0232581.
    PubMed     Abstract available

  52. LI X, Shen X, Zhou Y, Wang X, et al
    Classification of breast cancer histopathological images using interleaved DenseNet with SENet (IDSNet).
    PLoS One. 2020;15:e0232127.
    PubMed     Abstract available

  53. CHEN VC, Lin KY, Tsai YH, Weng JC, et al
    Connectome analysis of brain functional network alterations in breast cancer survivors with and without chemotherapy.
    PLoS One. 2020;15:e0232548.
    PubMed     Abstract available

  54. GARCIA-VAZQUEZ V, Calvo FA, Ledesma-Carbayo MJ, Sole CV, et al
    Intraoperative computed tomography imaging for dose calculation in intraoperative electron radiation therapy: Initial clinical observations.
    PLoS One. 2020;15:e0227155.
    PubMed     Abstract available

  55. AHN S, Chung YR, Seo AN, Kim M, et al
    Changes and prognostic values of tumor-infiltrating lymphocyte subsets after primary systemic therapy in breast cancer.
    PLoS One. 2020;15:e0233037.
    PubMed     Abstract available

  56. LINDENBERG M, van Beek A, Retel V, van Duijnhoven F, et al
    Early budget impact analysis on magnetic seed localization for non-palpable breast cancer surgery.
    PLoS One. 2020;15:e0232690.
    PubMed     Abstract available

  57. ANDERSON O, Guttilla Reed IK
    Regulation of cell growth and migration by miR-96 and miR-183 in a breast cancer model of epithelial-mesenchymal transition.
    PLoS One. 2020;15:e0233187.
    PubMed     Abstract available

  58. STUEBER TN, Diessner J, Bartmann C, Leinert E, et al
    Effect of adjuvant radiotherapy in elderly patients with breast cancer.
    PLoS One. 2020;15:e0229518.
    PubMed     Abstract available

  59. DING Y, Ding K, Yang H, He X, et al
    Does dose-dense neoadjuvant chemotherapy have clinically significant prognostic value in breast cancer?: A meta-analysis of 3,724 patients.
    PLoS One. 2020;15:e0234058.
    PubMed     Abstract available

  60. YEERKEN D, Hong R, Wang Y, Gong Y, et al
    PFKP is transcriptionally repressed by BRCA1/ZBRK1 and predicts prognosis in breast cancer.
    PLoS One. 2020;15:e0233750.
    PubMed     Abstract available

  61. OMASANGGAR R, Yu CY, Ang GY, Emran NA, et al
    Mitochondrial DNA mutations in Malaysian female breast cancer patients.
    PLoS One. 2020;15:e0233461.
    PubMed     Abstract available

  62. CHENG Y, Huang Z, Liao Q, Yu X, et al
    Risk of second primary breast cancer among cancer survivors: Implications for prevention and screening practice.
    PLoS One. 2020;15:e0232800.
    PubMed     Abstract available

  63. ZHENG J, Wu J, Wang C, Zhuang S, et al
    Combination cyclin-dependent kinase 4/6 inhibitors and endocrine therapy versus endocrine monotherapy for hormonal receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0233571.
    PubMed     Abstract available

  64. RASMUSSEN GHF, Kristiansen M, Arroyo-Morales M, Voigt M, et al
    Absolute and relative reliability of pain sensitivity and functional outcomes of the affected shoulder among women with pain after breast cancer treatment.
    PLoS One. 2020;15:e0234118.
    PubMed     Abstract available

  65. WONG KK, Hussain FA
    TRPM4 is overexpressed in breast cancer associated with estrogen response and epithelial-mesenchymal transition gene sets.
    PLoS One. 2020;15:e0233884.
    PubMed     Abstract available

  66. TRILLA-FUERTES L, Gamez-Pozo A, Arevalillo JM, Lopez-Vacas R, et al
    Bayesian networks established functional differences between breast cancer subtypes.
    PLoS One. 2020;15:e0234752.
    PubMed     Abstract available

  67. DISCALA M, Najor MS, Yung T, Morgan D, et al
    Loss of STAT6 leads to anchorage-independent growth and trastuzumab resistance in HER2+ breast cancer cells.
    PLoS One. 2020;15:e0234146.
    PubMed     Abstract available

  68. LABROSSE J, Osdoit M, Hamy AS, Coussy F, et al
    Adjuvant chemotherapy for breast cancer after preoperative chemotherapy: A propensity score matched analysis.
    PLoS One. 2020;15:e0234173.
    PubMed     Abstract available

  69. MOON HR, Ospina-Munoz N, Noe-Kim V, Yang Y, et al
    Subtype-specific characterization of breast cancer invasion using a microfluidic tumor platform.
    PLoS One. 2020;15:e0234012.
    PubMed     Abstract available

  70. BUSS LA, Ang AD, Hock B, Robinson BA, et al
    Effect of post-implant exercise on tumour growth rate, perfusion and hypoxia in mice.
    PLoS One. 2020;15:e0229290.
    PubMed     Abstract available

  71. LEE C, Han M, Baek J
    Human observer performance on in-plane digital breast tomosynthesis images: Effects of reconstruction filters and data acquisition angles on signal detection.
    PLoS One. 2020;15:e0229915.
    PubMed     Abstract available

  72. DEMIRCIOGLU A, Grueneisen J, Ingenwerth M, Hoffmann O, et al
    A rapid volume of interest-based approach of radiomics analysis of breast MRI for tumor decoding and phenotyping of breast cancer.
    PLoS One. 2020;15:e0234871.
    PubMed     Abstract available

  73. RAISNER R, Bainer R, Haverty PM, Benedetti KL, et al
    Super-enhancer acquisition drives oncogene expression in triple negative breast cancer.
    PLoS One. 2020;15:e0235343.
    PubMed     Abstract available

  74. OKUMA H, Sudah M, Kettunen T, Niukkanen A, et al
    Peritumor to tumor apparent diffusion coefficient ratio is associated with biologically more aggressive breast cancer features and correlates with the prognostication tools.
    PLoS One. 2020;15:e0235278.
    PubMed     Abstract available

  75. BURGUIN A, Furrer D, Ouellette G, Jacob S, et al
    Trastuzumab effects depend on HER2 phosphorylation in HER2-negative breast cancer cell lines.
    PLoS One. 2020;15:e0234991.
    PubMed     Abstract available

  76. HAMY AS, Darrigues L, Laas E, De Croze D, et al
    Prognostic value of the Residual Cancer Burden index according to breast cancer subtype: Validation on a cohort of BC patients treated by neoadjuvant chemotherapy.
    PLoS One. 2020;15:e0234191.
    PubMed     Abstract available

  77. Retraction: Macrophage Colony-Stimulating Factor Augments Tie2-Expressing Monocyte Differentiation, Angiogenic Function, and Recruitment in a Mouse Model of Breast Cancer.
    PLoS One. 2020;15:e0235096.

  78. NEWTON A, Predina J, Mison M, Runge J, et al
    Intraoperative near-infrared imaging can identify canine mammary tumors, a spontaneously occurring, large animal model of human breast cancer.
    PLoS One. 2020;15:e0234791.
    PubMed     Abstract available

  79. THIJSSEN B, Wessels LFA
    Approximating multivariate posterior distribution functions from Monte Carlo samples for sequential Bayesian inference.
    PLoS One. 2020;15:e0230101.
    PubMed     Abstract available

  80. ARCHER S, Babb de Villiers C, Scheibl F, Carver T, et al
    Evaluating clinician acceptability of the prototype CanRisk tool for predicting risk of breast and ovarian cancer: A multi-methods study.
    PLoS One. 2020;15:e0229999.
    PubMed     Abstract available

  81. TANAKA M, Hsuan C, Oeki M, Shen W, et al
    Identification of characteristic compounds of moderate volatility in breast cancer cell lines.
    PLoS One. 2020;15:e0235442.
    PubMed     Abstract available

  82. THURING J, Kuhl CK, Barabasch A, Hitpass L, et al
    Signal changes in T2-weighted MRI of liver metastases under bevacizumab-A practical imaging biomarker?
    PLoS One. 2020;15:e0230553.
    PubMed     Abstract available

  83. RAINES MILENKOV A, Felini M, Baker E, Acharya R, et al
    Uptake of cancer screenings among a multiethnic refugee population in North Texas, 2014-2018.
    PLoS One. 2020;15:e0230675.
    PubMed     Abstract available

  84. HAILU HE, Mondul AM, Rozek LS, Geleta T, et al
    Descriptive Epidemiology of breast and gynecological cancers among patients attending Saint Paul's Hospital Millennium Medical College, Ethiopia.
    PLoS One. 2020;15:e0230625.
    PubMed     Abstract available

  85. DE KRUIF AJ, Chrifou R, Langeslag GL, Sondaal AEC, et al
    Perceptions of non-Western immigrant women on having breast cancer and their experiences with treatment-related changes in body weight and lifestyle: A qualitative study.
    PLoS One. 2020;15:e0235662.
    PubMed     Abstract available

  86. ULYTE A, Wei W, Dressel H, Gruebner O, et al
    Variation of colorectal, breast and prostate cancer screening activity in Switzerland: Influence of insurance, policy and guidelines.
    PLoS One. 2020;15:e0231409.
    PubMed     Abstract available

  87. MAYORAL-VARO V, Calcabrini A, Sanchez-Bailon MP, Martinez-Costa OH, et al
    c-Src functionality controls self-renewal and glucose metabolism in MCF7 breast cancer stem cells.
    PLoS One. 2020;15:e0235850.
    PubMed     Abstract available

  88. NOZAKI Y, Motomura H, Tamori S, Kimura Y, et al
    High PKClambda expression is required for ALDH1-positive cancer stem cell function and indicates a poor clinical outcome in late-stage breast cancer patients.
    PLoS One. 2020;15:e0235747.
    PubMed     Abstract available

  89. HIENSCH AE, Peeters PHM, Jansen M, van der Wall E, et al
    Socio-ecological correlates of physical activity in breast and colon cancer survivors 4 years after participation in a randomized controlled exercise trial (PACT study).
    PLoS One. 2020;15:e0231663.
    PubMed     Abstract available

  90. WALSH CA, Akrap N, Garre E, Magnusson Y, et al
    The mevalonate precursor enzyme HMGCS1 is a novel marker and key mediator of cancer stem cell enrichment in luminal and basal models of breast cancer.
    PLoS One. 2020;15:e0236187.
    PubMed     Abstract available

  91. SHAHZAD N, Munir T, Javed M, Tasneem F, et al
    SHISA3, an antagonist of the Wnt/beta-catenin signaling, is epigenetically silenced and its ectopic expression suppresses growth in breast cancer.
    PLoS One. 2020;15:e0236192.
    PubMed     Abstract available

  92. BARE DJ, Cherny VV, DeCoursey TE, Abukhdeir AM, et al
    Expression and function of voltage gated proton channels (Hv1) in MDA-MB-231 cells.
    PLoS One. 2020;15:e0227522.
    PubMed     Abstract available

  93. AKIN E, Pelen NN, Tiryaki IU, Yalcin F, et al
    Parameter identification for gompertz and logistic dynamic equations.
    PLoS One. 2020;15:e0230582.
    PubMed     Abstract available

  94. GASILINA A, Premnauth G, Gurjar P, Biesiada J, et al
    IODVA1, a guanidinobenzimidazole derivative, targets Rac activity and Ras-driven cancer models.
    PLoS One. 2020;15:e0229801.
    PubMed     Abstract available

  95. YOO JJ, Lim YS, Kim MS, Lee B, et al
    Risk of fatty liver after long-term use of tamoxifen in patients with breast cancer.
    PLoS One. 2020;15:e0236506.
    PubMed     Abstract available

  96. QUIAOIT K, DiCenzo D, Fatima K, Bhardwaj D, et al
    Quantitative ultrasound radiomics for therapy response monitoring in patients with locally advanced breast cancer: Multi-institutional study results.
    PLoS One. 2020;15:e0236182.
    PubMed     Abstract available

    In silico analyses identify lncRNAs: WDFY3-AS2, BDNF-AS and AFAP1-AS1 as potential prognostic factors for patients with triple-negative breast tumors.
    PLoS One. 2020;15:e0232284.
    PubMed     Abstract available

  98. BADRAN A, Tul-Wahab A, Zafar H, Mohammad N, et al
    Antipsychotics drug aripiprazole as a lead against breast cancer cell line (MCF-7) in vitro.
    PLoS One. 2020;15:e0235676.
    PubMed     Abstract available

  99. ARIK A, Dodd E, Streftaris G
    Cancer morbidity trends and regional differences in England-A Bayesian analysis.
    PLoS One. 2020;15:e0232844.
    PubMed     Abstract available

  100. WIELEMA M, Dorrius MD, Pijnappel RM, De Bock GH, et al
    Diagnostic performance of breast tumor tissue selection in diffusion weighted imaging: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0232856.
    PubMed     Abstract available

  101. DRUCKER A, Teh EM, Kostyleva R, Rayson D, et al
    Comparative performance of different methods for circulating tumor cell enrichment in metastatic breast cancer patients.
    PLoS One. 2020;15:e0237308.
    PubMed     Abstract available

  102. VIJAYASARVESWARI V, Andrew AM, Jusoh M, Sabapathy T, et al
    Multi-stage feature selection (MSFS) algorithm for UWB-based early breast cancer size prediction.
    PLoS One. 2020;15:e0229367.
    PubMed     Abstract available

  103. ELSHARKAWY M, Vestring T, Raatschen HJ
    A ten-year, single-center experience: Concordance between breast core needle biopsy/vacuum-assisted biopsy and postoperative histopathology in B3 and B5a cases.
    PLoS One. 2020;15:e0233574.
    PubMed     Abstract available

  104. WAWRZYNIAK D, Grabowska M, Glodowicz P, Kuczynski K, et al
    Down-regulation of tenascin-C inhibits breast cancer cells development by cell growth, migration, and adhesion impairment.
    PLoS One. 2020;15:e0237889.
    PubMed     Abstract available

  105. AMINA M, Al Musayeib NM, Alarfaj NA, El-Tohamy MF, et al
    Biogenic green synthesis of MgO nanoparticles using Saussurea costus biomasses for a comprehensive detection of their antimicrobial, cytotoxicity against MCF-7 breast cancer cells and photocatalysis potentials.
    PLoS One. 2020;15:e0237567.
    PubMed     Abstract available

  106. PEPLONSKA B, Janasik B, McCormack V, Bukowska-Damska A, et al
    Cadmium and volumetric mammographic density: A cross-sectional study in Polish women.
    PLoS One. 2020;15:e0233369.
    PubMed     Abstract available

  107. JANK P, Gehlhaar C, Bianca L, Caterina F, et al
    MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial.
    PLoS One. 2020;15:e0238021.
    PubMed     Abstract available

  108. JO W
    Funding sources and breast cancer research frame.
    PLoS One. 2020;15:e0238026.
    PubMed     Abstract available

  109. DE-LA-CRUZ-KU G, Luyo M, Morante Z, Enriquez D, et al
    Triple-negative breast cancer in Peru: 2000 patients and 15 years of experience.
    PLoS One. 2020;15:e0237811.
    PubMed     Abstract available

  110. HOU H, Lyu Y, Jiang J, Wang M, et al
    Peripheral blood transcriptome identifies high-risk benign and malignant breast lesions.
    PLoS One. 2020;15:e0233713.
    PubMed     Abstract available

  111. SANTOS-SANCHEZ V, Cordoba-Dona JA, Viciana F, Escolar-Pujolar A, et al
    Geographical variations in cancer mortality and social inequalities in southern Spain (Andalusia). 2002-2013.
    PLoS One. 2020;15:e0233397.
    PubMed     Abstract available

  112. PHILIPOVSKIY A, Dwivedi AK, Gamez R, McCallum R, et al
    Association between tumor mutation profile and clinical outcomes among Hispanic Latina women with triple-negative breast cancer.
    PLoS One. 2020;15:e0238262.
    PubMed     Abstract available

  113. FERRANTI M, Pinnarelli L, Rosa A, Pastorino R, et al
    Evaluation of the breast cancer care network within the Lazio Region (Central Italy).
    PLoS One. 2020;15:e0238562.
    PubMed     Abstract available

  114. BISHOP MR, Omeler-Fenaud SM, Huskey ALW, Merner ND, et al
    Gene panel screening for insight towards breast cancer susceptibility in different ethnicities.
    PLoS One. 2020;15:e0238295.
    PubMed     Abstract available

  115. CUTLER W, Kolter J, Chambliss C, O'Neill H, et al
    Long term absence of invasive breast cancer diagnosis in 2,402,672 pre and postmenopausal women: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0237925.
    PubMed     Abstract available

  116. PORTER W, Snowden E, Hahn F, Ferguson M, et al
    High accuracy gene expression profiling of sorted cell subpopulations from breast cancer PDX model tissue.
    PLoS One. 2020;15:e0238594.
    PubMed     Abstract available

  117. TANIGUCHI K, Takada S, Omori M, Igawa T, et al
    Triple-negative pleomorphic lobular carcinoma and expression of androgen receptor: Personal case series and review of the literature.
    PLoS One. 2020;15:e0235790.
    PubMed     Abstract available

    January 2019
  118. SCHUETZ JM, Grundy A, Lee DG, Lai AS, et al
    Genetic variants in genes related to inflammation, apoptosis and autophagy in breast cancer risk.
    PLoS One. 2019;14:e0209010.
    PubMed     Abstract available

  119. LIU M, Yang Y, Xie F, Guo J, et al
    Could axillary clearance be avoided in clinically node-negative breast cancer patients with positive nodes diagnosed by ultrasound guided biopsy in the post-ACOSOG Z0011 era?
    PLoS One. 2019;14:e0210437.
    PubMed     Abstract available

  120. LAI YL, Su YC, Kao CH, Liang JA, et al
    Increased risk of varicella-zoster virus infection in patients with breast cancer after adjuvant radiotherapy: A population-based cohort study.
    PLoS One. 2019;14:e0209365.
    PubMed     Abstract available

  121. SHARMA A, Bandyopadhayaya S, Chowdhury K, Sharma T, et al
    Metformin exhibited anticancer activity by lowering cellular cholesterol content in breast cancer cells.
    PLoS One. 2019;14:e0209435.
    PubMed     Abstract available

  122. BONSU AB, Ncama BP
    Recognizing and appraising symptoms of breast cancer as a reason for delayed presentation in Ghanaian women: A qualitative study.
    PLoS One. 2019;14:e0208773.
    PubMed     Abstract available

  123. WATANABE T, Yagata H, Saito M, Okada H, et al
    A multicenter survey of temporal changes in chemotherapy-induced hair loss in breast cancer patients.
    PLoS One. 2019;14:e0208118.
    PubMed     Abstract available

  124. MOUSAVI SA, Kasaeian A, Pourkasmaee M, Ghavamzadeh A, et al
    Assessing the prognostic factors, survival, and recurrence incidence of triple negative breast cancer patients, a single center study in Iran.
    PLoS One. 2019;14:e0208701.
    PubMed     Abstract available

  125. MORGAT C, Schollhammer R, Macgrogan G, Barthe N, et al
    Comparison of the binding of the gastrin-releasing peptide receptor (GRP-R) antagonist 68Ga-RM2 and 18F-FDG in breast cancer samples.
    PLoS One. 2019;14:e0210905.
    PubMed     Abstract available

  126. CHATSIPROIOS D, Schmidts-Winkler IM, Konig L, Masur C, et al
    Topical treatment of vaginal dryness with a non-hormonal cream in women undergoing breast cancer treatment - An open prospective multicenter study.
    PLoS One. 2019;14:e0210967.
    PubMed     Abstract available

  127. VAN MAAREN MC, Kneepkens RF, Verbaan J, Huijgens PC, et al
    A conditional model predicting the 10-year annual extra mortality risk compared to the general population: a large population-based study in Dutch breast cancer patients.
    PLoS One. 2019;14:e0210887.
    PubMed     Abstract available

  128. LAAS E, Hamy AS, Michel AS, Panchbhaya N, et al
    Impact of time to local recurrence on the occurrence of metastasis in breast cancer patients treated with neoadjuvant chemotherapy: A random forest survival approach.
    PLoS One. 2019;14:e0208807.
    PubMed     Abstract available

  129. SHOWALTER LE, Oechsle C, Ghimirey N, Steele C, et al
    Th1 cytokines sensitize HER-expressing breast cancer cells to lapatinib.
    PLoS One. 2019;14:e0210209.
    PubMed     Abstract available

  130. Retraction: Plumbagin Suppresses the Invasion of HER2-Overexpressing Breast Cancer Cells through Inhibition of IKKalpha-Mediated NF-kappaB Activation.
    PLoS One. 2019;14:e0207273.

  131. KECHAVARZI BD, Wu H, Doman TN
    Bottom-up, integrated -omics analysis identifies broadly dosage-sensitive genes in breast cancer samples from TCGA.
    PLoS One. 2019;14:e0210910.
    PubMed     Abstract available

  132. CHITAPANARUX I, Nobnop W, Tippanya D, Sripan P, et al
    Clinical outcomes and dosimetric study of hypofractionated Helical TomoTherapy in breast cancer patients.
    PLoS One. 2019;14:e0211578.
    PubMed     Abstract available

  133. PIETERS HC, Green E, Khakshooy S, Sleven M, et al
    A qualitative comparison of how older breast cancer survivors process treatment information regarding endocrine therapy.
    PLoS One. 2019;14:e0210972.
    PubMed     Abstract available

  134. MICHEL LL, Sommer L, Gonzalez Silos R, Lorenzo Bermejo J, et al
    Prediction of local recurrence risk after neoadjuvant chemotherapy in patients with primary breast cancer: Clinical utility of the MD Anderson Prognostic Index.
    PLoS One. 2019;14:e0211337.
    PubMed     Abstract available

  135. Expression of Concern: Ramentaceone, a Naphthoquinone Derived from Drosera sp., Induces Apoptosis by Suppressing PI3K/Akt Signaling in Breast Cancer Cells.
    PLoS One. 2019;14:e0211655.

  136. WILLIAMS LA, Casbas-Hernandez P, Nichols HB, Tse CK, et al
    Risk factors for Luminal A ductal carcinoma in situ (DCIS) and invasive breast cancer in the Carolina Breast Cancer Study.
    PLoS One. 2019;14:e0211488.
    PubMed     Abstract available

  137. HEBERT-MAGEE S, Yu H, Behring M, Jadhav T, et al
    The combined survival effect of codon 72 polymorphisms and p53 somatic mutations in breast cancer depends on race and molecular subtype.
    PLoS One. 2019;14:e0211734.
    PubMed     Abstract available

  138. LYNG FM, Traynor D, Nguyen TNQ, Meade AD, et al
    Discrimination of breast cancer from benign tumours using Raman spectroscopy.
    PLoS One. 2019;14:e0212376.
    PubMed     Abstract available

  139. COLLIN LJ, McCullough LE, Conway K, White AJ, et al
    Reproductive characteristics modify the association between global DNA methylation and breast cancer risk in a population-based sample of women.
    PLoS One. 2019;14:e0210884.
    PubMed     Abstract available

  140. PEARLMAN A, Rahman MT, Upadhyay K, Loke J, et al
    Ectopic Otoconin 90 expression in triple negative breast cancer cell lines is associated with metastasis functions.
    PLoS One. 2019;14:e0211737.
    PubMed     Abstract available

  141. MURPHY C, Muscat A, Ashley D, Mukaro V, et al
    Tailored NEOadjuvant epirubicin, cyclophosphamide and Nanoparticle Albumin-Bound paclitaxel for breast cancer: The phase II NEONAB trial-Clinical outcomes and molecular determinants of response.
    PLoS One. 2019;14:e0210891.
    PubMed     Abstract available

  142. MEYER SB, Foley K, Olver I, Ward PR, et al
    Alcohol and breast cancer risk: Middle-aged women's logic and recommendations for reducing consumption in Australia.
    PLoS One. 2019;14:e0211293.
    PubMed     Abstract available

  143. JIANG X, Wells A, Brufsky A, Neapolitan R, et al
    A clinical decision support system learned from data to personalize treatment recommendations towards preventing breast cancer metastasis.
    PLoS One. 2019;14:e0213292.
    PubMed     Abstract available

  144. OW SGW, Ong PY, Lee SC
    Discoveries beyond BRCA1/2: Multigene testing in an Asian multi-ethnic cohort suspected of hereditary breast cancer syndrome in the real world.
    PLoS One. 2019;14:e0213746.
    PubMed     Abstract available

  145. ROEHRER S, Stork V, Ludwig C, Minceva M, et al
    Analyzing bioactive effects of the minor hop compound xanthohumol C on human breast cancer cells using quantitative proteomics.
    PLoS One. 2019;14:e0213469.
    PubMed     Abstract available

  146. PIOTRZKOWSKA-WROBLEWSKA H, Dobruch-Sobczak K, Klimonda Z, Karwat P, et al
    Monitoring breast cancer response to neoadjuvant chemotherapy with ultrasound signal statistics and integrated backscatter.
    PLoS One. 2019;14:e0213749.
    PubMed     Abstract available

  147. EGELAND NG, Austdal M, van Diermen-Hidle B, Rewcastle E, et al
    Validation study of MARCKSL1 as a prognostic factor in lymph node-negative breast cancer patients.
    PLoS One. 2019;14:e0212527.
    PubMed     Abstract available

  148. DUCRET A, James I, Wilson S, Feilke M, et al
    Translation and evaluation of a pre-clinical 5-protein response prediction signature in a breast cancer phase Ib clinical trial.
    PLoS One. 2019;14:e0213892.
    PubMed     Abstract available

  149. WANG H, Xu C, Kong X, Li X, et al
    Correction: Trail Resistance Induces Epithelial-Mesenchymal Transition and Enhances Invasiveness by Suppressing PTEN via miR-221 in Breast Cancer.
    PLoS One. 2019;14:e0214433.
    PubMed     Abstract available

  150. BONSU AB, Ncama BP
    Integration of breast cancer prevention and early detection into cancer palliative care model.
    PLoS One. 2019;14:e0212806.
    PubMed     Abstract available

  151. VENTURA-ALFARO CE, Avila-Burgos L, Torres-Mejia G
    Adherence of Mexican physicians to clinical guidelines in the management of breast cancer: Effect of the National Catastrophic Health Expenditure Fund.
    PLoS One. 2019;14:e0212841.
    PubMed     Abstract available

  152. HOLMSTROM O, Linder N, Moilanen H, Suutala A, et al
    Detection of breast cancer lymph node metastases in frozen sections with a point-of-care low-cost microscope scanner.
    PLoS One. 2019;14:e0208366.
    PubMed     Abstract available

  153. JIANG Y, Chen L, Zhang H, Xiao X, et al
    Breast cancer histopathological image classification using convolutional neural networks with small SE-ResNet module.
    PLoS One. 2019;14:e0214587.
    PubMed     Abstract available

  154. WITTKOWSKI KM, Dadurian C, Seybold MP, Kim HS, et al
    Correction: Complex polymorphisms in endocytosis genes suggest alpha-cyclodextrin as a treatment for breast cancer.
    PLoS One. 2019;14:e0214826.
    PubMed     Abstract available

  155. ZITO P, Labbozzetta M, Notarbartolo M, Sajeva M, et al
    Essential oil of Cyphostemma juttae (Vitaceae): Chemical composition and antitumor mechanism in triple negative breast cancer cells.
    PLoS One. 2019;14:e0214594.
    PubMed     Abstract available

  156. ZHANG Y, Chen J, Wang Y, Wang D, et al
    Multilayer network analysis of miRNA and protein expression profiles in breast cancer patients.
    PLoS One. 2019;14:e0202311.
    PubMed     Abstract available

  157. BAATJES KJ, Kotze MJ, McCaul M, Conradie M, et al
    Baseline bone health status in multi-ethnic South African postmenopausal breast cancer patients at initiation of aromatase inhibitor therapy: A descriptive study.
    PLoS One. 2019;14:e0214153.
    PubMed     Abstract available

  158. SIDDIQUE AB, Ebrahim H, Mohyeldin M, Qusa M, et al
    Novel liquid-liquid extraction and self-emulsion methods for simplified isolation of extra-virgin olive oil phenolics with emphasis on (-)-oleocanthal and its oral anti-breast cancer activity.
    PLoS One. 2019;14:e0214798.
    PubMed     Abstract available

  159. BURTON LJ, Hawsawi O, Sweeney J, Bowen N, et al
    CCAAT-displacement protein/cut homeobox transcription factor (CUX1) represses estrogen receptor-alpha (ER-alpha) in triple-negative breast cancer cells and can be antagonized by muscadine grape skin extract (MSKE).
    PLoS One. 2019;14:e0214844.
    PubMed     Abstract available

  160. FURUYA Y
    Early neutropenia on day 8 treated with adjuvant Docetaxel-based chemotherapy in early breast cancer patients: Putative mechanisms within the neutrophil pool system.
    PLoS One. 2019;14:e0215576.
    PubMed     Abstract available

  161. PARE R, Soon PS, Shah A, Lee CS, et al
    Differential expression of senescence tumour markers and its implications on survival outcomes of breast cancer patients.
    PLoS One. 2019;14:e0214604.
    PubMed     Abstract available

  162. LYNG FM, Traynor D, Nguyen TNQ, Meade AD, et al
    Correction: Discrimination of breast cancer from benign tumours using Raman spectroscopy.
    PLoS One. 2019;14:e0216311.
    PubMed     Abstract available

  163. WEN WX, Leong CO
    Association of BRCA1- and BRCA2-deficiency with mutation burden, expression of PD-L1/PD-1, immune infiltrates, and T cell-inflamed signature in breast cancer.
    PLoS One. 2019;14:e0215381.
    PubMed     Abstract available

  164. LOI S, Michiels S, Baselga J, Bartlett JMS, et al
    Correction: PIK3CA Genotype and a PIK3CA Mutation-Related Gene Signature and Response to Everolimus and Letrozole in Estrogen Receptor Positive Breast Cancer.
    PLoS One. 2019;14:e0216175.
    PubMed     Abstract available

  165. NOYAN S, Gurdal H, Gur Dedeoglu B
    Involvement of miR-770-5p in trastuzumab response in HER2 positive breast cancer cells.
    PLoS One. 2019;14:e0215894.
    PubMed     Abstract available

  166. ADLER G, Kaufman G, Simon-Tuval T
    Healthcare utilization of breast cancer patients following telephone-based consultations of oncology nurse navigator via telemedical care.
    PLoS One. 2019;14:e0216365.
    PubMed     Abstract available

  167. TVEITARAS MK, Selheim F, Sortland K, Reed RK, et al
    Protein expression profiling of plasma and lungs at different stages of metastatic development in a human triple negative breast cancer xenograft model.
    PLoS One. 2019;14:e0215909.
    PubMed     Abstract available

  168. LEI K, He X, Yu L, Ni C, et al
    Breast cancer prognosis is better in patients who develop subsequent metachronous thyroid cancer.
    PLoS One. 2019;14:e0215948.
    PubMed     Abstract available

  169. SALGUERO-ARANDA C, Sancho-Mensat D, Canals-Lorente B, Sultan S, et al
    STAT6 knockdown using multiple siRNA sequences inhibits proliferation and induces apoptosis of human colorectal and breast cancer cell lines.
    PLoS One. 2019;14:e0207558.
    PubMed     Abstract available

  170. DIETEL E, Brobeil A, Delventhal L, Tag C, et al
    Crosstalks of the PTPIP51 interactome revealed in Her2 amplified breast cancer cells by the novel small molecule LDC3/Dynarrestin.
    PLoS One. 2019;14:e0216642.
    PubMed     Abstract available

  171. WITLOX L, Velthuis MJ, Boer JH, Steins Bisschop CN, et al
    Attendance and compliance with an exercise program during localized breast cancer treatment in a randomized controlled trial: The PACT study.
    PLoS One. 2019;14:e0215517.
    PubMed     Abstract available

  172. UHR K, Prager-van der Smissen WJC, Heine AAJ, Ozturk B, et al
    MicroRNAs as possible indicators of drug sensitivity in breast cancer cell lines.
    PLoS One. 2019;14:e0216400.
    PubMed     Abstract available

  173. ZHAO Q, Howard EW, Parris AB, Ma Z, et al
    Bisphenol AF promotes estrogen receptor-positive breast cancer cell proliferation through amphiregulin-mediated crosstalk with receptor tyrosine kinase signaling.
    PLoS One. 2019;14:e0216469.
    PubMed     Abstract available

  174. KIM N, Chung W, Eum HH, Lee HO, et al
    Alternative polyadenylation of single cells delineates cell types and serves as a prognostic marker in early stage breast cancer.
    PLoS One. 2019;14:e0217196.
    PubMed     Abstract available

  175. ARNOLD M, Pfeifer K, Quante AS
    Is risk-stratified breast cancer screening economically efficient in Germany?
    PLoS One. 2019;14:e0217213.
    PubMed     Abstract available

  176. MONSALVE-LANCHEROS A, Ibanez-Pinilla M, Ramirez-Clavijo S
    Detection of mammagloblin by RT-PCR as a biomarker for lymph node metastasis in breast cancer patients: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0216989.
    PubMed     Abstract available

  177. ZHANG X, Zhang B, Zhang P, Lian L, et al
    Norcantharidin regulates ERalpha signaling and tamoxifen resistance via targeting miR-873/CDK3 in breast cancer cells.
    PLoS One. 2019;14:e0217181.
    PubMed     Abstract available

  178. LANDRY AP, Zador Z, Haq R, Cusimano MD, et al
    Reclassification of breast cancer: Towards improved diagnosis and outcome.
    PLoS One. 2019;14:e0217036.
    PubMed     Abstract available

  179. KUROZUMI S, Yamaguchi Y, Matsumoto H, Kurosumi M, et al
    Utility of Ki67 labeling index, cyclin D1 expression, and ER-activity level in postmenopausal ER-positive and HER2-negative breast cancer with neoadjuvant chemo-endocrine therapy.
    PLoS One. 2019;14:e0217279.
    PubMed     Abstract available

  180. SALES-DIAS J, Silva G, Lamy M, Ferreira A, et al
    The Notch ligand DLL1 exerts carcinogenic features in human breast cancer cells.
    PLoS One. 2019;14:e0217002.
    PubMed     Abstract available

  181. SALEH ME, Gadalla R, Hassan H, Afifi A, et al
    The immunomodulatory role of tumor Syndecan-1 (CD138) on ex vivo tumor microenvironmental CD4+ T cell polarization in inflammatory and non-inflammatory breast cancer patients.
    PLoS One. 2019;14:e0217550.
    PubMed     Abstract available

  182. RATH M, Li Q, Li H, Lindstrom S, et al
    Evaluation of significant genome-wide association studies risk - SNPs in young breast cancer patients.
    PLoS One. 2019;14:e0216997.
    PubMed     Abstract available

  183. HAJJAR A, Ergun MA, Alagoz O, Rampurwala M, et al
    Cost-effectiveness of adjuvant paclitaxel and trastuzumab for early-stage node-negative, HER2-positive breast cancer.
    PLoS One. 2019;14:e0217778.
    PubMed     Abstract available

  184. Expression of Concern: Microenvironment Promotes Tumor Cell Reprogramming in Human Breast Cancer Cell Lines.
    PLoS One. 2019;14:e0217961.

  185. FULTANG N, Illendula A, Chen B, Wu C, et al
    Strictinin, a novel ROR1-inhibitor, represses triple negative breast cancer survival and migration via modulation of PI3K/AKT/GSK3ss activity.
    PLoS One. 2019;14:e0217789.
    PubMed     Abstract available

  186. ESPLUGAS R, Arenas M, Serra N, Belles M, et al
    Effect of radiotherapy on the expression of cardiovascular disease-related miRNA-146a, -155, -221 and -222 in blood of women with breast cancer.
    PLoS One. 2019;14:e0217443.
    PubMed     Abstract available

  187. GIUDICI F, Petracci E, Nanni O, Bottin C, et al
    Elevated levels of eEF1A2 protein expression in triple negative breast cancer relate with poor prognosis.
    PLoS One. 2019;14:e0218030.
    PubMed     Abstract available

  188. SHARP JW, Hippe DS, Nakigudde G, Anderson BO, et al
    Modifiable patient-related barriers and their association with breast cancer detection practices among Ugandan women without a diagnosis of breast cancer.
    PLoS One. 2019;14:e0217938.
    PubMed     Abstract available

  189. JUNG SY, Mancuso N, Papp J, Sobel E, et al
    Post genome-wide gene-environment interaction study: The effect of genetically driven insulin resistance on breast cancer risk using Mendelian randomization.
    PLoS One. 2019;14:e0218917.
    PubMed     Abstract available

  190. WESSELS DJ, Pradhan N, Park YN, Klepitsch MA, et al
    Reciprocal signaling and direct physical interactions between fibroblasts and breast cancer cells in a 3D environment.
    PLoS One. 2019;14:e0218854.
    PubMed     Abstract available

  191. EKDAHL HJELM T, Matovu A, Mugisha N, Lofgren J, et al
    Breast cancer care in Uganda: A multicenter study on the frequency of breast cancer surgery in relation to the incidence of breast cancer.
    PLoS One. 2019;14:e0219601.
    PubMed     Abstract available

  192. Retraction: Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients.
    PLoS One. 2019;14:e0219887.

  193. STUR E, Aristizabal-Pachon AF, Peronni KC, Agostini LP, et al
    Glyphosate-based herbicides at low doses affect canonical pathways in estrogen positive and negative breast cancer cell lines.
    PLoS One. 2019;14:e0219610.
    PubMed     Abstract available

  194. IMRAN M, Al-Wassia R, Alkhayyat SS, Baig M, et al
    Assessment of quality of life (QoL) in breast cancer patients by using EORTC QLQ-C30 and BR-23 questionnaires: A tertiary care center survey in the western region of Saudi Arabia.
    PLoS One. 2019;14:e0219093.
    PubMed     Abstract available

  195. HEQUET D, Huchon C, Soilly AL, Asselain B, et al
    Direct medical and non-medical costs of a one-year care pathway for early operable breast cancer: Results of a French multicenter prospective study.
    PLoS One. 2019;14:e0210917.
    PubMed     Abstract available

  196. HERR D, Wischnewsky M, Joukhadar R, Chow O, et al
    Does chemotherapy improve survival in patients with nodal positive luminal A breast cancer? A retrospective Multicenter Study.
    PLoS One. 2019;14:e0218434.
    PubMed     Abstract available

  197. TERAVA J, Tiainen L, Lamminmaki U, Kellokumpu-Lehtinen PL, et al
    Lectin nanoparticle assays for detecting breast cancer-associated glycovariants of cancer antigen 15-3 (CA15-3) in human plasma.
    PLoS One. 2019;14:e0219480.
    PubMed     Abstract available

  198. GEBREMARIAM A, Addissie A, Worku A, Assefa M, et al
    Perspectives of patients, family members, and health care providers on late diagnosis of breast cancer in Ethiopia: A qualitative study.
    PLoS One. 2019;14:e0220769.
    PubMed     Abstract available

  199. SARKAR A, Chanda A, Regmi SC, Karve K, et al
    Recombinant human PRG4 (rhPRG4) suppresses breast cancer cell invasion by inhibiting TGFbeta-Hyaluronan-CD44 signalling pathway.
    PLoS One. 2019;14:e0219697.
    PubMed     Abstract available

  200. Expression of Concern: Hydrazinocurcumin Encapsuled Nanoparticles "Re-Educate" Tumor-Associated Macrophages and Exhibit Anti-Tumor Effects on Breast Cancer Following STAT3 Suppression.
    PLoS One. 2019;14:e0220672.

  201. DI COSIMO S, La Verde N, Moretti A, Cazzaniga ME, et al
    Neoadjuvant eribulin mesylate following anthracycline and taxane in triple negative breast cancer: Results from the HOPE study.
    PLoS One. 2019;14:e0220644.
    PubMed     Abstract available

  202. POULADI N, Abdolahi S, Farajzadeh D, Hosseinpour Feizi MA, et al
    Haplotype and linkage disequilibrium of TP53-WRAP53 locus in Iranian-Azeri women with breast cancer.
    PLoS One. 2019;14:e0220727.
    PubMed     Abstract available

  203. WANG L, Xiao Y, Ping Y, Li J, et al
    Correction: Integrating Multi-Omics for Uncovering the Architecture of Cross-Talking Pathways in Breast Cancer.
    PLoS One. 2019;14:e0221483.
    PubMed     Abstract available

  204. BADGUJAR NV, Tarapara BV, Shah FD
    Computational analysis of high-risk SNPs in human CHK2 gene responsible for hereditary breast cancer: A functional and structural impact.
    PLoS One. 2019;14:e0220711.
    PubMed     Abstract available

  205. AMIRFALLAH A, Arason A, Einarsson H, Gudmundsdottir ET, et al
    High expression of the vacuole membrane protein 1 (VMP1) is a potential marker of poor prognosis in HER2 positive breast cancer.
    PLoS One. 2019;14:e0221413.
    PubMed     Abstract available

  206. CLEMENT-ZHAO A, Tanguy ML, Cottu P, De La Lande B, et al
    Toxicity of locoregional radiotherapy in combination with bevacizumab in patients with non-metastatic breast cancer (TOLERAB): Final long-term evaluation.
    PLoS One. 2019;14:e0221816.
    PubMed     Abstract available

  207. TIAN W, Yao Y, Fan G, Zhou Y, et al
    Changes in lipid profiles during and after (neo)adjuvant chemotherapy in women with early-stage breast cancer: A retrospective study.
    PLoS One. 2019;14:e0221866.
    PubMed     Abstract available

  208. YOON CI, Ahn SG, Bae SJ, Shin YJ, et al
    High A20 expression negatively impacts survival in patients with breast cancer.
    PLoS One. 2019;14:e0221721.
    PubMed     Abstract available

  209. SCHAFFAR R, Bouchardy C, Chappuis PO, Bodmer A, et al
    A population-based cohort of young women diagnosed with breast cancer in Geneva, Switzerland.
    PLoS One. 2019;14:e0222136.
    PubMed     Abstract available

  210. ABDEL-FATTAH M, Saeed H, El-Shennawy L, Shalaby M, et al
    The Arabian camel, Camelus dromedarius interferon epsilon: Functional expression, in vitro refolding, purification and cytotoxicity on breast cancer cell lines.
    PLoS One. 2019;14:e0213880.
    PubMed     Abstract available

  211. LU Y, Zhang L, Zhang Q, Zhang Y, et al
    The association of D-dimer with clinicopathological features of breast cancer and its usefulness in differential diagnosis: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0221374.
    PubMed     Abstract available

  212. SATOMI-TSUSHITA N, Shimomura A, Matsuzaki J, Yamamoto Y, et al
    Serum microRNA-based prediction of responsiveness to eribulin in metastatic breast cancer.
    PLoS One. 2019;14:e0222024.
    PubMed     Abstract available

  213. BROUWER A, De Laere B, van Dam PJ, Peeters D, et al
    HER-2 status of circulating tumor cells in a metastatic breast cancer cohort: A comparative study on characterization techniques.
    PLoS One. 2019;14:e0220906.
    PubMed     Abstract available

  214. ELBASHEER MMA, Alkhidir AGA, Mohammed SMA, Abbas AAH, et al
    Spatial distribution of breast cancer in Sudan 2010-2016.
    PLoS One. 2019;14:e0211085.
    PubMed     Abstract available

  215. HASSEN AM, Taye G, Gizaw M, Hussien FM, et al
    Quality of life and associated factors among patients with breast cancer under chemotherapy at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia.
    PLoS One. 2019;14:e0222629.
    PubMed     Abstract available

  216. CHEN HH, Lin CH, Chen DY, Chao WC, et al
    Risk of major autoimmune diseases in female breast cancer patients: A nationwide, population-based cohort study.
    PLoS One. 2019;14:e0222860.
    PubMed     Abstract available

  217. MUNOZ R, Hileeto D, Cruz-Munoz W, Wood GA, et al
    Suppressive impact of metronomic chemotherapy using UFT and/or cyclophosphamide on mediators of breast cancer dissemination and invasion.
    PLoS One. 2019;14:e0222580.
    PubMed     Abstract available

  218. BAGEGNI NA, Tao Y, Ademuyiwa FO
    Clinical outcomes with neoadjuvant versus adjuvant chemotherapy for triple negative breast cancer: A report from the National Cancer Database.
    PLoS One. 2019;14:e0222358.
    PubMed     Abstract available

  219. FUNAKOSHI Y, Wang Y, Semba T, Masuda H, et al
    Comparison of molecular profile in triple-negative inflammatory and non-inflammatory breast cancer not of mesenchymal stem-like subtype.
    PLoS One. 2019;14:e0222336.
    PubMed     Abstract available

  220. JUNG KH, Lee EJ, Park JW, Lee JH, et al
    EGF receptor stimulation shifts breast cancer cell glucose metabolism toward glycolytic flux through PI3 kinase signaling.
    PLoS One. 2019;14:e0221294.
    PubMed     Abstract available

  221. LI Y, Giorgi EE, Beckman KB, Caberto C, et al
    Association between mitochondrial genetic variation and breast cancer risk: The Multiethnic Cohort.
    PLoS One. 2019;14:e0222284.
    PubMed     Abstract available

  222. HALASZ LM, Patel SA, McDougall JA, Fedorenko C, et al
    Intensity modulated radiation therapy following lumpectomy in early-stage breast cancer: Patterns of use and cost consequences among Medicare beneficiaries.
    PLoS One. 2019;14:e0222904.
    PubMed     Abstract available

  223. CHIGNOLA R, Sega M, Molesini B, Baruzzi A, et al
    Collective radioresistance of T47D breast carcinoma cells is mediated by a Syncytin-1 homologous protein.
    PLoS One. 2019;14:e0206713.
    PubMed     Abstract available

  224. WINSLOW S, Scholz A, Rappl P, Brauss TF, et al
    Macrophages attenuate the transcription of CYP1A1 in breast tumor cells and enhance their proliferation.
    PLoS One. 2019;14:e0209694.
    PubMed     Abstract available

  225. LEE KJ, Piett CG, Andrews JF, Mann E, et al
    Defective base excision repair in the response to DNA damaging agents in triple negative breast cancer.
    PLoS One. 2019;14:e0223725.
    PubMed     Abstract available

  226. ZHAI Q, Fan J, Lin Q, Liu X, et al
    Tumor stromal type is associated with stromal PD-L1 expression and predicts outcomes in breast cancer.
    PLoS One. 2019;14:e0223325.
    PubMed     Abstract available

  227. DE LEMOS LLP, Carvalho de Souza M, Pena Moreira D, Ribeiro Fernandes Almeida PH, et al
    Stage at diagnosis and stage-specific survival of breast cancer in Latin America and the Caribbean: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0224012.
    PubMed     Abstract available

  228. SANTOYO-OLSSON J, Stewart AL, Samayoa C, Palomino H, et al
    Translating a stress management intervention for rural Latina breast cancer survivors: The Nuevo Amanecer-II.
    PLoS One. 2019;14:e0224068.
    PubMed     Abstract available

  229. SATO J, Shimomura A, Kawauchi J, Matsuzaki J, et al
    Brain metastasis-related microRNAs in patients with advanced breast cancer.
    PLoS One. 2019;14:e0221538.
    PubMed     Abstract available

  230. HILL DA, Prossnitz ER, Royce M, Nibbe A, et al
    Temporal trends in breast cancer survival by race and ethnicity: A population-based cohort study.
    PLoS One. 2019;14:e0224064.
    PubMed     Abstract available

  231. COWPPLI-BONY A, Tretarre B, Marrer E, Defossez G, et al
    Compliance with clinical guidelines for breast cancer management: A population-based study of quality-of-care indicators in France.
    PLoS One. 2019;14:e0224275.
    PubMed     Abstract available

  232. CHENG W, Shen X, Xing M
    Decreased breast cancer-specific mortality risk in patients with a history of thyroid cancer.
    PLoS One. 2019;14:e0221093.
    PubMed     Abstract available

  233. KIM HJ, Park JY, Lee TS, Song IH, et al
    PET imaging of HER2 expression with an 18F-fluoride labeled aptamer.
    PLoS One. 2019;14:e0211047.
    PubMed     Abstract available

  234. OLIVIER M, Bouaoun L, Villar S, Robitaille A, et al
    Molecular features of premenopausal breast cancers in Latin American women: Pilot results from the PRECAMA study.
    PLoS One. 2019;14:e0210372.
    PubMed     Abstract available

  235. DELGADO R, Nunez-Gonzalez JD
    Enhancing Confusion Entropy (CEN) for binary and multiclass classification.
    PLoS One. 2019;14:e0210264.
    PubMed     Abstract available

  236. TAVAKOLI TABA S, Brennan PC, Lewis S
    Dynamics of breast imaging research: A global scoping review and Sino-Australian comparison case study.
    PLoS One. 2019;14:e0210256.
    PubMed     Abstract available

  237. HELLERHOFF K, Birnbacher L, Sztrokay-Gaul A, Grandl S, et al
    Assessment of intraductal carcinoma in situ (DCIS) using grating-based X-ray phase-contrast CT at conventional X-ray sources: An experimental ex-vivo study.
    PLoS One. 2019;14:e0210291.
    PubMed     Abstract available

  238. FOKIALAKIS N, Alexi X, Aligiannis N, Boulaka A, et al
    Biological evaluation of isoflavonoids from Genista halacsyi using estrogen-target cells: Activities of glucosides compared to aglycones.
    PLoS One. 2019;14:e0210247.
    PubMed     Abstract available

  239. MANDRIK O, Yaumenenka A, Herrero R, Jonker MF, et al
    Population preferences for breast cancer screening policies: Discrete choice experiment in Belarus.
    PLoS One. 2019;14:e0224667.
    PubMed     Abstract available

  240. MENDONCA P, Horton A, Bauer D, Messeha S, et al
    The inhibitory effects of butein on cell proliferation and TNF-alpha-induced CCL2 release in racially different triple negative breast cancer cells.
    PLoS One. 2019;14:e0215269.
    PubMed     Abstract available

  241. SHAHRIYARI L, Abdel-Rahman M, Cebulla C
    BAP1 expression is prognostic in breast and uveal melanoma but not colon cancer and is highly positively correlated with RBM15B and USP19.
    PLoS One. 2019;14:e0211507.
    PubMed     Abstract available

  242. HUANG YH, Lee MS, Lou YS, Lai HC, et al
    Propofol-based total intravenous anesthesia did not improve survival compared to desflurane anesthesia in breast cancer surgery.
    PLoS One. 2019;14:e0224728.
    PubMed     Abstract available

  243. CURRY JM, Besmer DM, Erick TK, Steuerwald N, et al
    Indomethacin enhances anti-tumor efficacy of a MUC1 peptide vaccine against breast cancer in MUC1 transgenic mice.
    PLoS One. 2019;14:e0224309.
    PubMed     Abstract available

  244. AFKHAMI M, Schmolze D, Yost SE, Frankel PH, et al
    Mutation and immune profiling of metaplastic breast cancer: Correlation with survival.
    PLoS One. 2019;14:e0224726.
    PubMed     Abstract available

  245. HEDAYATI E, Fracheboud L, Srikant V, Greber D, et al
    Economic benefits of subcutaneous trastuzumab administration: A single institutional study from Karolinska University Hospital in Sweden.
    PLoS One. 2019;14:e0211783.
    PubMed     Abstract available

  246. MINAMI Y, Kanemura S, Kawai M, Nishino Y, et al
    Alcohol consumption and survival after breast cancer diagnosis in Japanese women: A prospective patient cohort study.
    PLoS One. 2019;14:e0224797.
    PubMed     Abstract available

  247. MREMI A, Broadwater G, Jackson K, Amsi P, et al
    Breast cancer in Tanzanian, black American, and white American women: An assessment of prognostic and predictive features, including tumor infiltrating lymphocytes.
    PLoS One. 2019;14:e0224760.
    PubMed     Abstract available

  248. TERRAZZINO S, Cargnin S, Deantonio L, Pisani C, et al
    Impact of ATM rs1801516 on late skin reactions of radiotherapy for breast cancer: Evidences from a cohort study and a trial sequential meta-analysis.
    PLoS One. 2019;14:e0225685.
    PubMed     Abstract available

  249. GIORDANO A, Liu Y, Armeson K, Park Y, et al
    Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer.
    PLoS One. 2019;14:e0224420.
    PubMed     Abstract available

  250. SSENTONGO P, Lewcun JA, Candela X, Ssentongo AE, et al
    Regional, racial, gender, and tumor biology disparities in breast cancer survival rates in Africa: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0225039.
    PubMed     Abstract available

  251. REDMOND AM, Omarjee S, Chernukhin I, Le Romancer M, et al
    Analysis of HER2 genomic binding in breast cancer cells identifies a global role in direct gene regulation.
    PLoS One. 2019;14:e0225180.
    PubMed     Abstract available

  252. LJEPOJA B, Schreiber C, Gegenfurtner FA, Garcia-Roman J, et al
    Inducible microRNA-200c decreases motility of breast cancer cells and reduces filamin A.
    PLoS One. 2019;14:e0224314.
    PubMed     Abstract available

  253. CATTEAU X, Simon P, Jondet M, Vanhaeverbeek M, et al
    Quantification of stromal reaction in breast carcinoma and its correlation with tumor grade and free progression survival.
    PLoS One. 2019;14:e0210263.
    PubMed     Abstract available

  254. CHENG W, Shen X, Xing M
    Correction: Decreased breast cancer-specific mortality risk in patients with a history of thyroid cancer.
    PLoS One. 2019;14:e0225986.
    PubMed     Abstract available

  255. RUPJI M, Dwivedi B, Kowalski J
    NOJAH: NOt Just Another Heatmap for genome-wide cluster analysis.
    PLoS One. 2019;14:e0204542.
    PubMed     Abstract available

  256. FORGET P, Bouche G, Duhoux FP, Coulie PG, et al
    Intraoperative ketorolac in high-risk breast cancer patients. A prospective, randomized, placebo-controlled clinical trial.
    PLoS One. 2019;14:e0225748.
    PubMed     Abstract available

  257. TETEH D, Ericson M, Monice S, Dawkins-Moultin L, et al
    The Black identity, hair product use, and breast cancer scale.
    PLoS One. 2019;14:e0225305.
    PubMed     Abstract available

  258. PARK J, Shin Y, Kim TH, Kim DH, et al
    Plasma metabolites as possible biomarkers for diagnosis of breast cancer.
    PLoS One. 2019;14:e0225129.
    PubMed     Abstract available

  259. YOO B, Meka N, Sheedy P, Billig AM, et al
    MicroRNA-710 regulates multiple pathways of carcinogenesis in murine metastatic breast cancer.
    PLoS One. 2019;14:e0226356.
    PubMed     Abstract available

  260. Retraction: Ramentaceone, a Naphthoquinone Derived from Drosera sp., Induces Apoptosis by Suppressing PI3K/Akt Signaling in Breast Cancer Cells.
    PLoS One. 2019;14:e0226703.

  261. WEN W, Xuan D, Hu Y, Li X, et al
    Prognostic value of maximum standard uptake value, metabolic tumor volume, and total lesion glycolysis of positron emission tomography/computed tomography in patients with breast cancer: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0225959.
    PubMed     Abstract available

  262. JOGI A, Ehinger A, Hartman L, Alkner S, et al
    Expression of HIF-1alpha is related to a poor prognosis and tamoxifen resistance in contralateral breast cancer.
    PLoS One. 2019;14:e0226150.
    PubMed     Abstract available

  263. PARK HS, Lee JD, Kim JY, Park S, et al
    Establishment of chemosensitivity tests in triple-negative and BRCA-mutated breast cancer patient-derived xenograft models.
    PLoS One. 2019;14:e0225082.
    PubMed     Abstract available

  264. ROMAN M, Sala M, Domingo L, Posso M, et al
    Personalized breast cancer screening strategies: A systematic review and quality assessment.
    PLoS One. 2019;14:e0226352.
    PubMed     Abstract available

  265. TALMONT F, Mouledous L, Baranger M, Gomez-Brouchet A, et al
    Development and characterization of sphingosine 1-phosphate receptor 1 monoclonal antibody suitable for cell imaging and biochemical studies of endogenous receptors.
    PLoS One. 2019;14:e0213203.
    PubMed     Abstract available

  266. STARK GF, Hart GR, Nartowt BJ, Deng J, et al
    Predicting breast cancer risk using personal health data and machine learning models.
    PLoS One. 2019;14:e0226765.
    PubMed     Abstract available

  267. GIUDICI F, Petracci E, Nanni O, Bottin C, et al
    Correction: Elevated levels of eEF1A2 protein expression in triple negative breast cancer relate with poor prognosis.
    PLoS One. 2019;14:e0227068.
    PubMed     Abstract available

  268. JIANG Y, Weinberg CR, Sandler DP, Zhao S, et al
    Use of detailed family history data to improve risk prediction,with application to breast cancer screening.
    PLoS One. 2019;14:e0226407.
    PubMed     Abstract available

  269. LEE SJ, Sim TS, Shin HY, Lee J, et al
    Microslit on a chip: A simplified filter to capture circulating tumor cells enlarged with microbeads.
    PLoS One. 2019;14:e0223193.
    PubMed     Abstract available

  270. SHETH M, Gerovitch A, Welsch R, Markuzon N, et al
    The Univariate Flagging Algorithm (UFA): An interpretable approach for predictive modeling.
    PLoS One. 2019;14:e0223161.
    PubMed     Abstract available

  271. HECK L, Dierolf M, Jud C, Eggl E, et al
    Contrast-enhanced spectral mammography with a compact synchrotron source.
    PLoS One. 2019;14:e0222816.
    PubMed     Abstract available

  272. WU WP, Wu HK, Chen CJ, Lee CW, et al
    Higher underestimation of tumour size post-neoadjuvant chemotherapy with breast magnetic resonance imaging (MRI)-A concordance comparison cohort analysis.
    PLoS One. 2019;14:e0222917.
    PubMed     Abstract available

  273. ABECASSIS J, Hamy AS, Laurent C, Sadacca B, et al
    Assessing reliability of intra-tumor heterogeneity estimates from single sample whole exome sequencing data.
    PLoS One. 2019;14:e0224143.
    PubMed     Abstract available

  274. SHON EJ, Townsend AL
    Predictors of never having a mammogram among Chinese, Vietnamese, and Korean immigrant women in the U.S.
    PLoS One. 2019;14:e0224505.
    PubMed     Abstract available

  275. YLOSMAKI L, Polini B, Carpi S, Martins B, et al
    Harnessing therapeutic viruses as a delivery vehicle for RNA-based therapy.
    PLoS One. 2019;14:e0224072.
    PubMed     Abstract available

  276. PETROVIC K, Robinson J, Whitworth K, Jinks E, et al
    TEM8/ANTXR1-specific CAR T cells mediate toxicity in vivo.
    PLoS One. 2019;14:e0224015.
    PubMed     Abstract available

  277. IWATA TN, Sugihara K, Wada T, Agatsuma T, et al
    [Fam-] trastuzumab deruxtecan (DS-8201a)-induced antitumor immunity is facilitated by the anti-CTLA-4 antibody in a mouse model.
    PLoS One. 2019;14:e0222280.
    PubMed     Abstract available

  278. ALHAKAMY NA, Fahmy UA, Ahmed OAA
    Vitamin E TPGS based transferosomes augmented TAT as a promising delivery system for improved transdermal delivery of raloxifene.
    PLoS One. 2019;14:e0226639.
    PubMed     Abstract available

  279. NAKAMOTO S, Hirose M
    Prediction of early C-reactive protein levels after non-cardiac surgery under general anesthesia.
    PLoS One. 2019;14:e0226032.
    PubMed     Abstract available

    January 2018
  280. OLIVEIRA MMF, Gurgel MSC, Amorim BJ, Ramos CD, et al
    Long term effects of manual lymphatic drainage and active exercises on physical morbidities, lymphoscintigraphy parameters and lymphedema formation in patients operated due to breast cancer: A clinical trial.
    PLoS One. 2018;13:e0189176.
    PubMed     Abstract available

  281. THAKUR SS, Li H, Chan AMY, Tudor R, et al
    The use of automated Ki67 analysis to predict Oncotype DX risk-of-recurrence categories in early-stage breast cancer.
    PLoS One. 2018;13:e0188983.
    PubMed     Abstract available

  282. SANNACHI L, Gangeh M, Tadayyon H, Sadeghi-Naini A, et al
    Response monitoring of breast cancer patients receiving neoadjuvant chemotherapy using quantitative ultrasound, texture, and molecular features.
    PLoS One. 2018;13:e0189634.
    PubMed     Abstract available

  283. HADJIALIREZAEI S, Picco G, Beatson R, Burchell J, et al
    Correction: Interactions between the breast cancer-associated MUC1 mucins and C-type lectin characterized by optical tweezers.
    PLoS One. 2018;13:e0190814.
    PubMed     Abstract available

  284. KROIGARD AB, Larsen MJ, Laenkholm AV, Knoop AS, et al
    Identification of metastasis driver genes by massive parallel sequencing of successive steps of breast cancer progression.
    PLoS One. 2018;13:e0189887.
    PubMed     Abstract available

  285. BROMBERG SE, Moraes PRAF, Ades F
    Prime incision: A minimally invasive approach to breast cancer surgical treatment-A 2 cohort retrospective comparison with conventional breast conserving surgery.
    PLoS One. 2018;13:e0191056.
    PubMed     Abstract available

  286. HILDENBRAND G, Metzler P, Pilarczyk G, Bobu V, et al
    Dose enhancement effects of gold nanoparticles specifically targeting RNA in breast cancer cells.
    PLoS One. 2018;13:e0190183.
    PubMed     Abstract available

  287. LI T, Zhao J, Yang J, Ma X, et al
    Correction: A Meta-Analysis of the Association between ESR1 Genetic Variants and the Risk of Breast Cancer.
    PLoS One. 2018;13:e0191579.
    PubMed     Abstract available

  288. KHALIS M, Charbotel B, Chajes V, Rinaldi S, et al
    Menstrual and reproductive factors and risk of breast cancer: A case-control study in the Fez region, Morocco.
    PLoS One. 2018;13:e0191333.
    PubMed     Abstract available

  289. TSAI HP, Huang SF, Li CF, Chien HT, et al
    Differential microRNA expression in breast cancer with different onset age.
    PLoS One. 2018;13:e0191195.
    PubMed     Abstract available

  290. SYED BM, Morgan D, Setty T, Green AR, et al
    Correction: Oestrogen receptor negative early operable primary breast cancer in older women-Biological characteristics and long-term clinical outcome.
    PLoS One. 2018;13:e0191979.
    PubMed     Abstract available

  291. KIM J, Choi SH, Ham SJ, Cho YC, et al
    Evaluation of drug mechanism and efficacy of a novel anti-angiogenic agent, TTAC-0001, using multi-modality bioimaging in a mouse breast cancer orthotopic model.
    PLoS One. 2018;13:e0187063.
    PubMed     Abstract available

  292. BOUGARET L, Delort L, Billard H, Le Huede C, et al
    Adipocyte/breast cancer cell crosstalk in obesity interferes with the anti-proliferative efficacy of tamoxifen.
    PLoS One. 2018;13:e0191571.
    PubMed     Abstract available

  293. KHAN MM, Mendes A, Chalup SK
    Evolutionary Wavelet Neural Network ensembles for breast cancer and Parkinson's disease prediction.
    PLoS One. 2018;13:e0192192.
    PubMed     Abstract available

  294. RUSSO-ABRAHAO T, Lacerda-Abreu MA, Gomes T, Cosentino-Gomes D, et al
    Characterization of inorganic phosphate transport in the triple-negative breast cancer cell line, MDA-MB-231.
    PLoS One. 2018;13:e0191270.
    PubMed     Abstract available

  295. BELCHER DA, Ju JA, Baek JH, Yalamanoglu A, et al
    The quaternary state of polymerized human hemoglobin regulates oxygenation of breast cancer solid tumors: A theoretical and experimental study.
    PLoS One. 2018;13:e0191275.
    PubMed     Abstract available

  296. BRADFORD JR, Cox A, Bernard P, Camp NJ, et al
    Correction: Consensus Analysis of Whole Transcriptome Profiles from Two Breast Cancer Patient Cohorts Reveals Long Non-Coding RNAs Associated with Intrinsic Subtype and the Tumour Microenvironment.
    PLoS One. 2018;13:e0192589.
    PubMed     Abstract available

  297. ZHANG J, Yang J, Zhang X, Xu J, et al
    MicroRNA-10b expression in breast cancer and its clinical association.
    PLoS One. 2018;13:e0192509.
    PubMed     Abstract available

  298. JOFFE M, Ayeni O, Norris SA, McCormack VA, et al
    Barriers to early presentation of breast cancer among women in Soweto, South Africa.
    PLoS One. 2018;13:e0192071.
    PubMed     Abstract available

  299. PATEL N, Garikapati KR, Makani VKK, Nair AD, et al
    Regulating BMI1 expression via miRNAs promote Mesenchymal to Epithelial Transition (MET) and sensitizes breast cancer cell to chemotherapeutic drug.
    PLoS One. 2018;13:e0190245.
    PubMed     Abstract available

  300. VACHER S, Castagnet P, Chemlali W, Lallemand F, et al
    High AHR expression in breast tumors correlates with expression of genes from several signaling pathways namely inflammation and endogenous tryptophan metabolism.
    PLoS One. 2018;13:e0190619.
    PubMed     Abstract available

  301. THAKRAN S, Chatterjee S, Singhal M, Gupta RK, et al
    Automatic outer and inner breast tissue segmentation using multi-parametric MRI images of breast tumor patients.
    PLoS One. 2018;13:e0190348.
    PubMed     Abstract available

  302. CALA MP, Aldana J, Medina J, Sanchez J, et al
    Multiplatform plasma metabolic and lipid fingerprinting of breast cancer: A pilot control-case study in Colombian Hispanic women.
    PLoS One. 2018;13:e0190958.
    PubMed     Abstract available

  303. ROHAN T, Ye K, Wang Y, Glass AG, et al
    MicroRNA expression in benign breast tissue and risk of subsequent invasive breast cancer.
    PLoS One. 2018;13:e0191814.
    PubMed     Abstract available

  304. YUAN H, Chen V, Boisvert M, Isaacs C, et al
    PLAC1 as a serum biomarker for breast cancer.
    PLoS One. 2018;13:e0192106.
    PubMed     Abstract available

  305. ZIAI J, Gilbert HN, Foreman O, Eastham-Anderson J, et al
    CD8+ T cell infiltration in breast and colon cancer: A histologic and statistical analysis.
    PLoS One. 2018;13:e0190158.
    PubMed     Abstract available

  306. HO PJ, Hartman M, Young-Afat DA, Gernaat SAM, et al
    Determinants of satisfaction with cosmetic outcome in breast cancer survivors: A cross-sectional study.
    PLoS One. 2018;13:e0193099.
    PubMed     Abstract available

  307. JENSEN-JOHANSEN MB, O'Toole MS, Christensen S, Valdimarsdottir H, et al
    Expressive writing intervention and self-reported physical health out-comes - Results from a nationwide randomized controlled trial with breast cancer patients.
    PLoS One. 2018;13:e0192729.
    PubMed     Abstract available

  308. DE GROEF A, Van Kampen M, Moortgat P, Anthonissen M, et al
    An evaluation tool for Myofascial Adhesions in Patients after Breast Cancer (MAP-BC evaluation tool): Concurrent, face and content validity.
    PLoS One. 2018;13:e0193915.
    PubMed     Abstract available

  309. BOSE C, Awasthi S, Sharma R, Benes H, et al
    Sulforaphane potentiates anticancer effects of doxorubicin and attenuates its cardiotoxicity in a breast cancer model.
    PLoS One. 2018;13:e0193918.
    PubMed     Abstract available

  310. HUSSAIN A, Yong C, Tkaczuk KHR, Qian Y, et al
    Prevalence and risk of skeletal complications and use of radiation therapy in elderly women diagnosed with metastatic breast cancer.
    PLoS One. 2018;13:e0193661.
    PubMed     Abstract available

  311. ALMOTWAA S, Elrobh M, AbdulKarim H, Alanazi M, et al
    Genetic polymorphism and expression of HSF1 gene is significantly associated with breast cancer in Saudi females.
    PLoS One. 2018;13:e0193095.
    PubMed     Abstract available

  312. VREEMANN S, Gubern-Merida A, Borelli C, Bult P, et al
    The correlation of background parenchymal enhancement in the contralateral breast with patient and tumor characteristics of MRI-screen detected breast cancers.
    PLoS One. 2018;13:e0191399.
    PubMed     Abstract available

  313. LAGUNIN AA, Dubovskaja VI, Rudik AV, Pogodin PV, et al
    CLC-Pred: A freely available web-service for in silico prediction of human cell line cytotoxicity for drug-like compounds.
    PLoS One. 2018;13:e0191838.
    PubMed     Abstract available

  314. ZHAO X, Wei J, Li X, Yang H, et al
    Increasing negative lymph node count predicts favorable OS and DSS in breast cancer with different lymph node-positive subgroups.
    PLoS One. 2018;13:e0193784.
    PubMed     Abstract available

  315. HELLEC C, Delos M, Carpentier M, Denys A, et al
    The heparan sulfate 3-O-sulfotransferases (HS3ST) 2, 3B and 4 enhance proliferation and survival in breast cancer MDA-MB-231 cells.
    PLoS One. 2018;13:e0194676.
    PubMed     Abstract available

  316. MAHMUD A, Aljunid SM
    Availability and accessibility of subsidized mammogram screening program in peninsular Malaysia: A preliminary study using travel impedance approach.
    PLoS One. 2018;13:e0191764.
    PubMed     Abstract available

  317. DVORAK KM, Pettee KM, Rubinic-Minotti K, Su R, et al
    Carcinoma associated fibroblasts (CAFs) promote breast cancer motility by suppressing mammalian Diaphanous-related formin-2 (mDia2).
    PLoS One. 2018;13:e0195278.
    PubMed     Abstract available

  318. ARYAL B, Rao VA
    Specific protein carbonylation in human breast cancer tissue compared to adjacent healthy epithelial tissue.
    PLoS One. 2018;13:e0194164.
    PubMed     Abstract available

  319. TAMEZ-PENA JG, Rodriguez-Rojas JA, Gomez-Rueda H, Celaya-Padilla JM, et al
    Radiogenomics analysis identifies correlations of digital mammography with clinical molecular signatures in breast cancer.
    PLoS One. 2018;13:e0193871.
    PubMed     Abstract available

  320. KHAJAH MA, Mathew PM, Luqmani YA
    Na+/K+ ATPase activity promotes invasion of endocrine resistant breast cancer cells.
    PLoS One. 2018;13:e0193779.
    PubMed     Abstract available

  321. NGUYEN CP, Adang EMM
    Cost-effectiveness of breast cancer screening using mammography in Vietnamese women.
    PLoS One. 2018;13:e0194996.
    PubMed     Abstract available

  322. BROMBERG SE, Moraes PRAF, Ades F
    Correction: Prime incision: A minimally invasive approach to breast cancer surgical treatment-A 2 cohort retrospective comparison with conventional breast conserving surgery.
    PLoS One. 2018;13:e0195130.
    PubMed     Abstract available

  323. LUENGO-GIL G, Gonzalez-Billalabeitia E, Perez-Henarejos SA, Navarro Manzano E, et al
    Angiogenic role of miR-20a in breast cancer.
    PLoS One. 2018;13:e0194638.
    PubMed     Abstract available

  324. BAMBHROLIYA A, Van Wyhe RD, Kumar S, Debeb BG, et al
    Gene set analysis of post-lactational mammary gland involution gene signatures in inflammatory and triple-negative breast cancer.
    PLoS One. 2018;13:e0192689.
    PubMed     Abstract available

  325. HAN Q, Chen R, Wang F, Chen S, et al
    Pre-exposure to 50 Hz-electromagnetic fields enhanced the antiproliferative efficacy of 5-fluorouracil in breast cancer MCF-7 cells.
    PLoS One. 2018;13:e0192888.
    PubMed     Abstract available

  326. LUCHSINGER C, Aguilar M, Burgos PV, Ehrenfeld P, et al
    Functional disruption of the Golgi apparatus protein ARF1 sensitizes MDA-MB-231 breast cancer cells to the antitumor drugs Actinomycin D and Vinblastine through ERK and AKT signaling.
    PLoS One. 2018;13:e0195401.
    PubMed     Abstract available

  327. HORIBATA S, Rice EJ, Zheng H, Mukai C, et al
    A bi-stable feedback loop between GDNF, EGR1, and ERalpha contribute to endocrine resistant breast cancer.
    PLoS One. 2018;13:e0194522.
    PubMed     Abstract available

  328. HORIBATA S, Rice EJ, Mukai C, Marks BA, et al
    ER-positive breast cancer cells are poised for RET-mediated endocrine resistance.
    PLoS One. 2018;13:e0194023.
    PubMed     Abstract available

  329. NAM SY, Ko ES, Lim Y, Han BK, et al
    Preoperative dynamic breast magnetic resonance imaging kinetic features using computer-aided diagnosis: Association with survival outcome and tumor aggressiveness in patients with invasive breast cancer.
    PLoS One. 2018;13:e0195756.
    PubMed     Abstract available

  330. CHU LW, John EM, Yang B, Kurian AW, et al
    Measuring serum melatonin in postmenopausal women: Implications for epidemiologic studies and breast cancer studies.
    PLoS One. 2018;13:e0195666.
    PubMed     Abstract available

  331. SANDLIN RD, Wong KHK, Tessier SN, Swei A, et al
    Ultra-fast vitrification of patient-derived circulating tumor cell lines.
    PLoS One. 2018;13:e0192734.
    PubMed     Abstract available

  332. SEO IS, Lee HG, Koo B, Koh CS, et al
    Cross detection for odor of metabolic waste between breast and colorectal cancer using canine olfaction.
    PLoS One. 2018;13:e0192629.
    PubMed     Abstract available

  333. KORONOWICZ AA, Drozdowska M, Wielgos B, Piasna-Slupecka E, et al
    The effect of "NutramilTM Complex," food for special medical purpose, on breast and prostate carcinoma cells.
    PLoS One. 2018;13:e0192860.
    PubMed     Abstract available

  334. DEWALD JH, Cavdarli S, Steenackers A, Delannoy CP, et al
    TNF differentially regulates ganglioside biosynthesis and expression in breast cancer cell lines.
    PLoS One. 2018;13:e0196369.
    PubMed     Abstract available

  335. PARISE C, Caggiano V
    The influence of marital status and race/ethnicity on risk of mortality for triple negative breast cancer.
    PLoS One. 2018;13:e0196134.
    PubMed     Abstract available

  336. TISSIER R, Houwing-Duistermaat J, Rodriguez-Girondo M
    Improving stability of prediction models based on correlated omics data by using network approaches.
    PLoS One. 2018;13:e0192853.
    PubMed     Abstract available

  337. FRICKE IB, De Souza R, Costa Ayub L, Francia G, et al
    Spatiotemporal assessment of spontaneous metastasis formation using multimodal in vivo imaging in HER2+ and triple negative metastatic breast cancer xenograft models in mice.
    PLoS One. 2018;13:e0196892.
    PubMed     Abstract available

  338. VERONESE P, Hachul DT, Scanavacca MI, Hajjar LA, et al
    Effects of anthracycline, cyclophosphamide and taxane chemotherapy on QTc measurements in patients with breast cancer.
    PLoS One. 2018;13:e0196763.
    PubMed     Abstract available

  339. KOVAC B, Makela TP, Vallenius T
    Increased alpha-actinin-1 destabilizes E-cadherin-based adhesions and associates with poor prognosis in basal-like breast cancer.
    PLoS One. 2018;13:e0196986.
    PubMed     Abstract available

  340. SENARAS C, Niazi MKK, Sahiner B, Pennell MP, et al
    Optimized generation of high-resolution phantom images using cGAN: Application to quantification of Ki67 breast cancer images.
    PLoS One. 2018;13:e0196846.
    PubMed     Abstract available

  341. FATIMA I, El-Ayachi I, Taotao L, Angeles Lillo M, et al
    Correction: The natural compound Jatrophone interferes with Wnt/beta-catenin signaling and inhibits proliferation and EMT in human triple-negative breast cancer.
    PLoS One. 2018;13:e0197796.
    PubMed     Abstract available

  342. ECKHARDT BL, Gagliardi M, Iles L, Evans K, et al
    Clinically relevant inflammatory breast cancer patient-derived xenograft-derived ex vivo model for evaluation of tumor-specific therapies.
    PLoS One. 2018;13:e0195932.
    PubMed     Abstract available

  343. LIM ST, Park CH, Kim SY, Nam SJ, et al
    The effect of adjuvant chemotherapy on survival in Korean patients with node negative T1c, triple negative breast cancer.
    PLoS One. 2018;13:e0197523.
    PubMed     Abstract available

  344. ZENG Z, Jiang X, Li X, Wells A, et al
    Conjugated equine estrogen and medroxyprogesterone acetate are associated with decreased risk of breast cancer relative to bioidentical hormone therapy and controls.
    PLoS One. 2018;13:e0197064.
    PubMed     Abstract available

  345. KHARMAN-BIZ A, Gao H, Ghiasvand R, Haldosen LA, et al
    Expression of the three components of linear ubiquitin assembly complex in breast cancer.
    PLoS One. 2018;13:e0197183.
    PubMed     Abstract available

  346. RACCAGNI I, Belloli S, Valtorta S, Stefano A, et al
    [18F]FDG and [18F]FLT PET for the evaluation of response to neo-adjuvant chemotherapy in a model of triple negative breast cancer.
    PLoS One. 2018;13:e0197754.
    PubMed     Abstract available

  347. Retraction: Calcium Channel Blockers and Risk of Breast Cancer: A Meta-Analysis of 17 Observational Studies.
    PLoS One. 2018;13:e0198220.

  348. STRUIK GM, Vrijland WW, Birnie E, Klem TMAL, et al
    A randomized controlled trial on the effect of a silver carboxymethylcellulose dressing on surgical site infections after breast cancer surgery.
    PLoS One. 2018;13:e0195715.
    PubMed     Abstract available

  349. HUBBELING HG, Rosenberg SM, Gonzalez-Robledo MC, Cohn JG, et al
    Psychosocial needs of young breast cancer survivors in Mexico City, Mexico.
    PLoS One. 2018;13:e0197931.
    PubMed     Abstract available

  350. PAVANELLO S, Varesco L, Gismondi V, Bruzzi P, et al
    Leucocytes telomere length and breast cancer risk/ susceptibility: A case-control study.
    PLoS One. 2018;13:e0197522.
    PubMed     Abstract available

  351. RAINEY L, van der Waal D, Donnelly LS, Evans DG, et al
    Women's decision-making regarding risk-stratified breast cancer screening and prevention from the perspective of international healthcare professionals.
    PLoS One. 2018;13:e0197772.
    PubMed     Abstract available

  352. HARALDSDOTTIR A, Torfadottir JE, Valdimarsdottir UA, Adami HO, et al
    Dietary habits in adolescence and midlife and risk of breast cancer in older women.
    PLoS One. 2018;13:e0198017.
    PubMed     Abstract available

  353. GHOSH A, Sarkar S, Banerjee S, Behbod F, et al
    MIND model for triple-negative breast cancer in syngeneic mice for quick and sequential progression analysis of lung metastasis.
    PLoS One. 2018;13:e0198143.
    PubMed     Abstract available

  354. VEYS I, Pop CF, Barbieux R, Moreau M, et al
    ICG fluorescence imaging as a new tool for optimization of pathological evaluation in breast cancer tumors after neoadjuvant chemotherapy.
    PLoS One. 2018;13:e0197857.
    PubMed     Abstract available

  355. ALHAMAMI M, Cheng W, Lyu Y, Allen C, et al
    Manganese-porphyrin-enhanced MRI for the detection of cancer cells: A quantitative in vitro investigation with multiple clinical subtypes of breast cancer.
    PLoS One. 2018;13:e0196998.
    PubMed     Abstract available

  356. CRUZ-ROA A, Gilmore H, Basavanhally A, Feldman M, et al
    High-throughput adaptive sampling for whole-slide histopathology image analysis (HASHI) via convolutional neural networks: Application to invasive breast cancer detection.
    PLoS One. 2018;13:e0196828.
    PubMed     Abstract available

  357. GU S, Ngamcherdtrakul W, Reda M, Hu Z, et al
    Lack of acquired resistance in HER2-positive breast cancer cells after long-term HER2 siRNA nanoparticle treatment.
    PLoS One. 2018;13:e0198141.
    PubMed     Abstract available

  358. FORMA E, Jozwiak P, Ciesielski P, Zaczek A, et al
    Impact of OGT deregulation on EZH2 target genes FOXA1 and FOXC1 expression in breast cancer cells.
    PLoS One. 2018;13:e0198351.
    PubMed     Abstract available

  359. HAN X, Zhao J, Ruddy KJ, Lin CC, et al
    The impact of dependent coverage expansion under the Affordable Care Act on time to breast cancer treatment among young women.
    PLoS One. 2018;13:e0198771.
    PubMed     Abstract available

  360. ASTVATSATURYAN K, Yue Y, Walts AE, Bose S, et al
    Androgen receptor positive triple negative breast cancer: Clinicopathologic, prognostic, and predictive features.
    PLoS One. 2018;13:e0197827.
    PubMed     Abstract available

  361. ALI S, Malik MZ, Singh SS, Chirom K, et al
    Exploring novel key regulators in breast cancer network.
    PLoS One. 2018;13:e0198525.
    PubMed     Abstract available

  362. EASTLACK SC, Dong S, Mo YY, Alahari SK, et al
    Expression of long noncoding RNA MALAT1 correlates with increased levels of Nischarin and inhibits oncogenic cell functions in breast cancer.
    PLoS One. 2018;13:e0198945.
    PubMed     Abstract available

  363. MCDONNELL SL, Baggerly CA, French CB, Baggerly LL, et al
    Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations >/=60 vs <20 ng/ml (150 vs 50 nmol/L): Pooled analysis of two randomized trials and a prospective cohort.
    PLoS One. 2018;13:e0199265.
    PubMed     Abstract available

  364. HENRY TR, Marshall SA, Avis NE, Levine BJ, et al
    Concordance networks and application to clustering cancer symptomology.
    PLoS One. 2018;13:e0191981.
    PubMed     Abstract available

  365. LESICKA M, Jablonska E, Wieczorek E, Seroczynska B, et al
    Altered circadian genes expression in breast cancer tissue according to the clinical characteristics.
    PLoS One. 2018;13:e0199622.
    PubMed     Abstract available

  366. BOYNE DJ, King WD, Brenner DR, McIntyre JB, et al
    Aerobic exercise and DNA methylation in postmenopausal women: An ancillary analysis of the Alberta Physical Activity and Breast Cancer Prevention (ALPHA) Trial.
    PLoS One. 2018;13:e0198641.
    PubMed     Abstract available

  367. LOBBA ARM, Carreira ACO, Cerqueira OLD, Fujita A, et al
    High CD90 (THY-1) expression positively correlates with cell transformation and worse prognosis in basal-like breast cancer tumors.
    PLoS One. 2018;13:e0199254.
    PubMed     Abstract available

  368. MARTIN CL, Tate DF, Valle CG
    Nonadherence to daily self-weighing and activity tracking is associated with weight fluctuations among African American breast cancer survivors.
    PLoS One. 2018;13:e0199751.
    PubMed     Abstract available

  369. VOUTOURI C, Stylianopoulos T
    Accumulation of mechanical forces in tumors is related to hyaluronan content and tissue stiffness.
    PLoS One. 2018;13:e0193801.
    PubMed     Abstract available

  370. HORIE Y, Makihara H, Horikawa K, Takeshige F, et al
    Reduced skin lipid content in obese Japanese women mediated by decreased expression of rate-limiting lipogenic enzymes.
    PLoS One. 2018;13:e0193830.
    PubMed     Abstract available

  371. GODLEWSKA M, Krasuska W, Czarnocka B
    Biochemical properties of thyroid peroxidase (TPO) expressed in human breast and mammary-derived cell lines.
    PLoS One. 2018;13:e0193624.
    PubMed     Abstract available

  372. WITTKOWSKI KM, Dadurian C, Seybold MP, Kim HS, et al
    Complex polymorphisms in endocytosis genes suggest alpha-cyclodextrin as a treatment for breast cancer.
    PLoS One. 2018;13:e0199012.
    PubMed     Abstract available

  373. CHEN Z, Ai L, Mboge MY, Tu C, et al
    Differential expression and function of CAIX and CAXII in breast cancer: A comparison between tumorgraft models and cells.
    PLoS One. 2018;13:e0199476.
    PubMed     Abstract available

  374. TAKABAYASHI M, Majeed H, Kajdacsy-Balla A, Popescu G, et al
    Disorder strength measured by quantitative phase imaging as intrinsic cancer marker in fixed tissue biopsies.
    PLoS One. 2018;13:e0194320.
    PubMed     Abstract available

  375. CHOI SW, Ryu SY, Han MA, Park J, et al
    Higher breast cancer prevalence associated with higher socioeconomic status in the South Korean population; Has it resulted from overdiagnosis?
    PLoS One. 2018;13:e0200484.
    PubMed     Abstract available

  376. KIM YY, Oh SJ, Chun YS, Lee WK, et al
    Gene expression assay and Watson for Oncology for optimization of treatment in ER-positive, HER2-negative breast cancer.
    PLoS One. 2018;13:e0200100.
    PubMed     Abstract available

  377. TYURYUMINA EY, Neznanov AA
    Consolidated mathematical growth model of the primary tumor and secondary distant metastases of breast cancer (CoMPaS).
    PLoS One. 2018;13:e0200148.
    PubMed     Abstract available

  378. SUN X, Stewart DA, Sandhu R, Kirk EL, et al
    Correlated metabolomic, genomic, and histologic phenotypes in histologically normal breast tissue.
    PLoS One. 2018;13:e0193792.
    PubMed     Abstract available

  379. BINDER K, Krauss S, Bruckmaier G, Marienhagen J, et al
    Visualizing the Bayesian 2-test case: The effect of tree diagrams on medical decision making.
    PLoS One. 2018;13:e0195029.
    PubMed     Abstract available

  380. PANNUTI A, Filipovic A, Hicks C, Lefkowitz E, et al
    Novel putative drivers revealed by targeted exome sequencing of advanced solid tumors.
    PLoS One. 2018;13:e0194790.
    PubMed     Abstract available

  381. SETYOWIBOWO H, Purba FD, Hunfeld JAM, Iskandarsyah A, et al
    Quality of life and health status of Indonesian women with breast cancer symptoms before the definitive diagnosis: A comparison with Indonesian women in general.
    PLoS One. 2018;13:e0200966.
    PubMed     Abstract available

  382. DEPARDON E, Kanoun S, Humbert O, Bertaut A, et al
    FDG PET/CT for prognostic stratification of patients with metastatic breast cancer treated with first line systemic therapy: Comparison of EORTC criteria and PERCIST.
    PLoS One. 2018;13:e0199529.
    PubMed     Abstract available

  383. MITCHELL R, Buckingham L, Cobleigh M, Rotmensch J, et al
    Can chimerism explain breast/ovarian cancers in BRCA non-carriers from BRCA-positive families?
    PLoS One. 2018;13:e0195497.
    PubMed     Abstract available

  384. PETURSSON HI, Kovacs A, Mattsson J, Olofsson Bagge R, et al
    Evaluation of intraoperative touch imprint cytology on axillary sentinel lymph nodes in invasive breast carcinomas, a retrospective study of 1227 patients comparing sensitivity in the different tumor subtypes.
    PLoS One. 2018;13:e0195560.
    PubMed     Abstract available

  385. AL-AJMI K, Lophatananon A, Ollier W, Muir KR, et al
    Risk of breast cancer in the UK biobank female cohort and its relationship to anthropometric and reproductive factors.
    PLoS One. 2018;13:e0201097.
    PubMed     Abstract available

  386. CHO U, Park HS, Im SY, Yoo CY, et al
    Prognostic value of systemic inflammatory markers and development of a nomogram in breast cancer.
    PLoS One. 2018;13:e0200936.
    PubMed     Abstract available

  387. GUO J, Liu C, Wang W, Liu Y, et al
    Identification of serum miR-1915-3p and miR-455-3p as biomarkers for breast cancer.
    PLoS One. 2018;13:e0200716.
    PubMed     Abstract available

  388. DANIELS B, Girosi F, Tervonen H, Kiely BE, et al
    Adherence to prescribing restrictions for HER2-positive metastatic breast cancer in Australia: A national population-based observational study (2001-2016).
    PLoS One. 2018;13:e0198152.
    PubMed     Abstract available

  389. HILTON J, Stober C, Mazzarello S, Vandermeer L, et al
    Randomised feasibility trial to compare three standard of care chemotherapy regimens for early stage triple-negative breast cancer (REaCT-TNBC trial).
    PLoS One. 2018;13:e0199297.
    PubMed     Abstract available

  390. KASSARDJIAN A, Shintaku PI, Moatamed NA
    Expression of immune checkpoint regulators, cytotoxic T lymphocyte antigen 4 (CTLA-4) and programmed death-ligand 1 (PD-L1), in female breast carcinomas.
    PLoS One. 2018;13:e0195958.
    PubMed     Abstract available

  391. GOUSSIA A, Simou N, Zagouri F, Manousou K, et al
    Associations of angiogenesis-related proteins with specific prognostic factors, breast cancer subtypes and survival outcome in early-stage breast cancer patients. A Hellenic Cooperative Oncology Group (HeCOG) trial.
    PLoS One. 2018;13:e0200302.
    PubMed     Abstract available

  392. MESSEHA SS, Zarmouh NO, Mendonca P, Alwagdani H, et al
    The inhibitory effects of plumbagin on the NF-B pathway and CCL2 release in racially different triple-negative breast cancer cells.
    PLoS One. 2018;13:e0201116.
    PubMed     Abstract available

  393. SAEUI CT, Nairn AV, Galizzi M, Douville C, et al
    Integration of genetic and metabolic features related to sialic acid metabolism distinguishes human breast cell subtypes.
    PLoS One. 2018;13:e0195812.
    PubMed     Abstract available

  394. OGATA H, Mitsuzuka Y, Honma N, Yoshida M, et al
    Sonographic visualization of nipple blood flow can help differentiate Paget disease from benign eczematous nipple lesions.
    PLoS One. 2018;13:e0197156.
    PubMed     Abstract available

  395. KUMAR V, Webb JM, Gregory A, Denis M, et al
    Automated and real-time segmentation of suspicious breast masses using convolutional neural network.
    PLoS One. 2018;13:e0195816.
    PubMed     Abstract available

  396. TSAI CW, Chang WS, Shen TC, Su CH, et al
    Contribution of excision repair cross-complementing group 1 genotypes to triple negative breast cancer risk.
    PLoS One. 2018;13:e0202112.
    PubMed     Abstract available

  397. Retraction: Functional Role of mTORC2 versus Integrin-Linked Kinase in Mediating Ser473-Akt Phosphorylation in PTEN-Negative Prostate and Breast Cancer Cell Lines.
    PLoS One. 2018;13:e0202299.

  398. LI X, Rouchka EC, Brock GN, Yan J, et al
    A combined approach with gene-wise normalization improves the analysis of RNA-seq data in human breast cancer subtypes.
    PLoS One. 2018;13:e0201813.
    PubMed     Abstract available

  399. UDDIN MM, Zou Y, Sharma T, Gatla HR, et al
    Proteasome inhibition induces IKK-dependent interleukin-8 expression in triple negative breast cancer cells: Opportunity for combination therapy.
    PLoS One. 2018;13:e0201858.
    PubMed     Abstract available

  400. BANNOUD N, Carvelli FL, Troncoso M, Sartor T, et al
    Cation-dependent mannose-6-phosphate receptor expression and distribution are influenced by estradiol in MCF-7 breast cancer cells.
    PLoS One. 2018;13:e0201844.
    PubMed     Abstract available

  401. KUROZUMI S, Matsumoto H, Inoue K, Tozuka K, et al
    Impact of combining the progesterone receptor and preoperative endocrine prognostic index (PEPI) as a prognostic factor after neoadjuvant endocrine therapy using aromatase inhibitors in postmenopausal ER positive and HER2 negative breast cancer.
    PLoS One. 2018;13:e0201846.
    PubMed     Abstract available

  402. COTE D, Eustace A, Toomey S, Cremona M, et al
    Germline single nucleotide polymorphisms in ERBB3 and BARD1 genes result in a worse relapse free survival response for HER2-positive breast cancer patients treated with adjuvant based docetaxel, carboplatin and trastuzumab (TCH).
    PLoS One. 2018;13:e0200996.
    PubMed     Abstract available

  403. FIGUEIREDO FWDS, Almeida TCDC, Schoueri JHM, Luisi C, et al
    Association between primary care coverage and breast cancer mortality in Brazil.
    PLoS One. 2018;13:e0200125.
    PubMed     Abstract available

  404. Retraction: Chaperonin CCT-Mediated AIB1 Folding Promotes the Growth of ERalpha-Positive Breast Cancer Cells on Hard Substrates.
    PLoS One. 2018;13:e0202617.

  405. GOMEZ-ACEBO I, Dierssen-Sotos T, Palazuelos C, Fernandez-Navarro P, et al
    Pigmentation phototype and prostate and breast cancer in a select Spanish population-A Mendelian randomization analysis in the MCC-Spain study.
    PLoS One. 2018;13:e0201750.
    PubMed     Abstract available

  406. KHALID S, Hanif R, Jabeen I, Mansoor Q, et al
    Pharmacophore modeling for identification of anti-IGF-1R drugs and in-vitro validation of fulvestrant as a potential inhibitor.
    PLoS One. 2018;13:e0196312.
    PubMed     Abstract available

  407. IPPOLITO E, Fiore M, Di Donato A, Silipigni S, et al
    Implementation of a voluntary deep inspiration breath hold technique (vDIBH) using BrainLab ExacTrac infrared optical tracking system.
    PLoS One. 2018;13:e0195506.
    PubMed     Abstract available

  408. GOMES RS, Moreira FTC, Fernandes R, Sales MGF, et al
    Sensing CA 15-3 in point-of-care by electropolymerizing O-phenylenediamine (oPDA) on Au-screen printed electrodes.
    PLoS One. 2018;13:e0196656.
    PubMed     Abstract available

  409. TARIQ H, Eldridge E, Welch I
    An efficient approach for feature construction of high-dimensional microarray data by random projections.
    PLoS One. 2018;13:e0196385.
    PubMed     Abstract available

  410. PANDE M, Joon A, Brewster AM, Chen WV, et al
    Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies.
    PLoS One. 2018;13:e0196245.
    PubMed     Abstract available

  411. YANG J, Min KW, Kim DH, Son BK, et al
    High TNFRSF12A level associated with MMP-9 overexpression is linked to poor prognosis in breast cancer: Gene set enrichment analysis and validation in large-scale cohorts.
    PLoS One. 2018;13:e0202113.
    PubMed     Abstract available

  412. CARIOU A, Rouzier R, Baffert S, Soilly AL, et al
    Multidimensional impact of breast cancer screening: Results of the multicenter prospective optisoins01 study.
    PLoS One. 2018;13:e0202385.
    PubMed     Abstract available

  413. RANASINGHE SL, Boyle GM, Fischer K, Potriquet J, et al
    Kunitz type protease inhibitor EgKI-1 from the canine tapeworm Echinococcus granulosus as a promising therapeutic against breast cancer.
    PLoS One. 2018;13:e0200433.
    PubMed     Abstract available

  414. COBO-CUENCA AI, Martin-Espinosa NM, Sampietro-Crespo A, Rodriguez-Borrego MA, et al
    Sexual dysfunction in Spanish women with breast cancer.
    PLoS One. 2018;13:e0203151.
    PubMed     Abstract available

  415. SMITH A, Mullooly M, Murphy L, Barron TI, et al
    Associations between obesity, smoking and lymph node status at breast cancer diagnosis in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
    PLoS One. 2018;13:e0202291.
    PubMed     Abstract available

  416. KOUSSEMOU M, Lorenz K, Klotz KN
    The A2B adenosine receptor in MDA-MB-231 breast cancer cells diminishes ERK1/2 phosphorylation by activation of MAPK-phosphatase-1.
    PLoS One. 2018;13:e0202914.
    PubMed     Abstract available

  417. BLACKBURN NE, Mc Veigh JG, Mc Caughan EM, Kennedy RD, et al
    The musculoskeletal consequences of latissmus dorsi breast reconstruction in women following mastectomy for breast cancer.
    PLoS One. 2018;13:e0202859.
    PubMed     Abstract available

  418. SCIOLI MG, Artuso S, D'Angelo C, Porru M, et al
    Adipose-derived stem cell-mediated paclitaxel delivery inhibits breast cancer growth.
    PLoS One. 2018;13:e0203426.
    PubMed     Abstract available

  419. TAMAYO LI, Vidaurre T, Navarro Vasquez J, Casavilca S, et al
    Breast cancer subtype and survival among Indigenous American women in Peru.
    PLoS One. 2018;13:e0201287.
    PubMed     Abstract available

  420. XU S, Thompson W, Kerr J, Godbole S, et al
    Modeling interrelationships between health behaviors in overweight breast cancer survivors: Applying Bayesian networks.
    PLoS One. 2018;13:e0202923.
    PubMed     Abstract available

  421. MON AM, MacKinnon AC Jr, Traktman P
    Overexpression of the VRK1 kinase, which is associated with breast cancer, induces a mesenchymal to epithelial transition in mammary epithelial cells.
    PLoS One. 2018;13:e0203397.
    PubMed     Abstract available

  422. GONG IY, Fox NS, Huang V, Boutros PC, et al
    Prediction of early breast cancer patient survival using ensembles of hypoxia signatures.
    PLoS One. 2018;13:e0204123.
    PubMed     Abstract available

  423. TAN MM, Ho WK, Yoon SY, Mariapun S, et al
    A case-control study of breast cancer risk factors in 7,663 women in Malaysia.
    PLoS One. 2018;13:e0203469.
    PubMed     Abstract available

  424. LI G, Guo X, Chen M, Tang L, et al
    Prevalence and spectrum of AKT1, PIK3CA, PTEN and TP53 somatic mutations in Chinese breast cancer patients.
    PLoS One. 2018;13:e0203495.
    PubMed     Abstract available

  425. YOO J, Kim BS, Chung J, Yoon HJ, et al
    Clinical value of delayed 18F-FDG PET/CT for predicting nipple-areolar complex involvement in breast cancer: A comparison with clinical symptoms and breast MRI.
    PLoS One. 2018;13:e0203649.
    PubMed     Abstract available

  426. LI J, Chen X, Qi M, Li Y, et al
    Sentinel lymph node biopsy mapped with methylene blue dye alone in patients with breast cancer: A systematic review and meta-analysis.
    PLoS One. 2018;13:e0204364.
    PubMed     Abstract available

  427. CHANCHAN G, Xiangyu S, Fangfang S, Yan C, et al
    The efficacy and safety of targeted therapy plus fulvestrant in postmenopausal women with hormone-receptor positive advanced breast cancer: A meta-analysis of randomized-control trials.
    PLoS One. 2018;13:e0204202.
    PubMed     Abstract available

  428. CALAHORRA J, Martinez-Lara E, De Dios C, Siles E, et al
    Hypoxia modulates the antioxidant effect of hydroxytyrosol in MCF-7 breast cancer cells.
    PLoS One. 2018;13:e0203892.
    PubMed     Abstract available

  429. DING LY, Chu M, Jiao YS, Hao Q, et al
    TFDP3 regulates the apoptosis and autophagy in breast cancer cell line MDA-MB-231.
    PLoS One. 2018;13:e0203833.
    PubMed     Abstract available

  430. LIN PH, Yang HJ, Hsieh WC, Lin C, et al
    Albumin and hemoglobin adducts of estrogen quinone as biomarkers for early detection of breast cancer.
    PLoS One. 2018;13:e0201241.
    PubMed     Abstract available

  431. FOUAD TM, Ueno NT, Yu RK, Ensor JE, et al
    Distinct epidemiological profiles associated with inflammatory breast cancer (IBC): A comprehensive analysis of the IBC registry at The University of Texas MD Anderson Cancer Center.
    PLoS One. 2018;13:e0204372.
    PubMed     Abstract available

  432. KAZEMI NOUREINI S, Fatemi L, Wink M
    Telomere shortening in breast cancer cells (MCF7) under treatment with low doses of the benzylisoquinoline alkaloid chelidonine.
    PLoS One. 2018;13:e0204901.
    PubMed     Abstract available

  433. Retraction: Mitochondrial Dysfunction Promotes Breast Cancer Cell Migration and Invasion through HIF1alpha Accumulation via Increased Production of Reactive Oxygen Species.
    PLoS One. 2018;13:e0205288.

  434. GOKMEN-POLAR Y, True JD, Vieth E, Gu Y, et al
    Quantitative phosphoproteomic analysis identifies novel functional pathways of tumor suppressor DLC1 in estrogen receptor positive breast cancer.
    PLoS One. 2018;13:e0204658.
    PubMed     Abstract available

  435. COLLIGNON O, Han J, An H, Oh S, et al
    Comparison of the modified unbounded penalty and the LASSO to select predictive genes of response to chemotherapy in breast cancer.
    PLoS One. 2018;13:e0204897.
    PubMed     Abstract available

  436. ANSARIPOUR A, Zendehdel K, Tadayon N, Sadeghi F, et al
    Use of data-mining to support real-world cost analyses: An example using HER2-positive breast cancer in Iran.
    PLoS One. 2018;13:e0205079.
    PubMed     Abstract available

  437. ZUGNI F, Ruju F, Pricolo P, Alessi S, et al
    The added value of whole-body magnetic resonance imaging in the management of patients with advanced breast cancer.
    PLoS One. 2018;13:e0205251.
    PubMed     Abstract available

  438. HARANO K, Wang Y, Lim B, Seitz RS, et al
    Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype.
    PLoS One. 2018;13:e0204513.
    PubMed     Abstract available

  439. VAN TREUREN T, Vishwanatha JK
    CRISPR deletion of MIEN1 in breast cancer cells.
    PLoS One. 2018;13:e0204976.
    PubMed     Abstract available

  440. HARALDSDOTTIR A, Torfadottir JE, Valdimarsdottir UA, Adami HO, et al
    Correction: Dietary habits in adolescence and midlife and risk of breast cancer in older women.
    PLoS One. 2018;13:e0206026.
    PubMed     Abstract available

  441. ALOTAIBI RM, Rezk HR, Juliana CI, Guure C, et al
    Breast cancer mortality in Saudi Arabia: Modelling observed and unobserved factors.
    PLoS One. 2018;13:e0206148.
    PubMed     Abstract available

  442. DUMANE VA, Bakst R, Green S
    Dose to organs in the supraclavicular region when covering the Internal Mammary Nodes (IMNs) in breast cancer patients: A comparison of Volumetric Modulated Arc Therapy (VMAT) versus 3D and VMAT.
    PLoS One. 2018;13:e0205770.
    PubMed     Abstract available

  443. COVARRUBIAS G, Cha A, Rahmy A, Lorkowski M, et al
    Imaging breast cancer using a dual-ligand nanochain particle.
    PLoS One. 2018;13:e0204296.
    PubMed     Abstract available

  444. SEMLALI A, Almutairi M, Rouabhia M, Reddy Parine N, et al
    Novel sequence variants in the TLR6 gene associated with advanced breast cancer risk in the Saudi Arabian population.
    PLoS One. 2018;13:e0203376.
    PubMed     Abstract available

  445. ROCHA-BRISCHILIARI SC, Andrade L, Nihei OK, Brischiliari A, et al
    Spatial distribution of breast cancer mortality: Socioeconomic disparities and access to treatment in the state of Parana, Brazil.
    PLoS One. 2018;13:e0205253.
    PubMed     Abstract available

  446. VENUGOPAL V, Krishnan S, Palanimuthu VR, Sankarankutty S, et al
    Anti-EGFR anchored paclitaxel loaded PLGA nanoparticles for the treatment of triple negative breast cancer. In-vitro and in-vivo anticancer activities.
    PLoS One. 2018;13:e0206109.
    PubMed     Abstract available

  447. BEZERRA IC, da Silva RM, Oliveira CP, Brasil CCP, et al
    Mastectomized women's perception of breast cancer early detection.
    PLoS One. 2018;13:e0206405.
    PubMed     Abstract available

  448. SALAGAME U, Banks E, O'Connell DL, Egger S, et al
    Menopausal Hormone Therapy use and breast cancer risk by receptor subtypes: Results from the New South Wales Cancer Lifestyle and EvaluAtion of Risk (CLEAR) study.
    PLoS One. 2018;13:e0205034.
    PubMed     Abstract available

  449. CUELLO-LOPEZ J, Fidalgo-Zapata A, Lopez-Agudelo L, Vasquez-Trespalacios E, et al
    Platelet-to-lymphocyte ratio as a predictive factor of complete pathologic response to neoadjuvant chemotherapy in breast cancer.
    PLoS One. 2018;13:e0207224.
    PubMed     Abstract available

  450. Correction: Manganese-porphyrin-enhanced MRI for the detection of cancer cells: A quantitative in vitro investigation with multiple clinical subtypes of breast cancer.
    PLoS One. 2018;13:e0206720.
    PubMed     Abstract available

  451. CAMPOS-RODRIGUEZ F, Cruz-Medina A, Selma MJ, Rodriguez-de-la-Borbolla-Artacho M, et al
    Association between sleep-disordered breathing and breast cancer aggressiveness.
    PLoS One. 2018;13:e0207591.
    PubMed     Abstract available

  452. KWON MJ, Lee SB, Han J, Lee JE, et al
    BCT score predicts chemotherapy benefit in Asian patients with hormone receptor-positive, HER2-negative, lymph node-negative breast cancer.
    PLoS One. 2018;13:e0207155.
    PubMed     Abstract available

  453. ALSHAREEDA AT, Rakha E, Alghwainem A, Alrfaei B, et al
    The effect of human placental chorionic villi derived mesenchymal stem cell on triple-negative breast cancer hallmarks.
    PLoS One. 2018;13:e0207593.
    PubMed     Abstract available

  454. MBOGE MY, Chen Z, Wolff A, Mathias JV, et al
    Selective inhibition of carbonic anhydrase IX over carbonic anhydrase XII in breast cancer cells using benzene sulfonamides: Disconnect between activity and growth inhibition.
    PLoS One. 2018;13:e0207417.
    PubMed     Abstract available

  455. GROSSE FRIE K, Kamate B, Traore CB, Ly M, et al
    Factors associated with time to first healthcare visit, diagnosis and treatment, and their impact on survival among breast cancer patients in Mali.
    PLoS One. 2018;13:e0207928.
    PubMed     Abstract available

  456. GOKAL K, Munir F, Ahmed S, Kancherla K, et al
    Does walking protect against decline in cognitive functioning among breast cancer patients undergoing chemotherapy? Results from a small randomised controlled trial.
    PLoS One. 2018;13:e0206874.
    PubMed     Abstract available

  457. SUN L, Legood R, Dos-Santos-Silva I, Gaiha SM, et al
    Global treatment costs of breast cancer by stage: A systematic review.
    PLoS One. 2018;13:e0207993.
    PubMed     Abstract available

  458. DAVIS M, Tripathi S, Hughley R, He Q, et al
    AR negative triple negative or "quadruple negative" breast cancers in African American women have an enriched basal and immune signature.
    PLoS One. 2018;13:e0196909.
    PubMed     Abstract available

  459. BALOGH KN, Templeton DJ, Cross JV
    Macrophage Migration Inhibitory Factor protects cancer cells from immunogenic cell death and impairs anti-tumor immune responses.
    PLoS One. 2018;13:e0197702.
    PubMed     Abstract available

  460. KOUTRAS A, Lazaridis G, Koliou GA, Kouvatseas G, et al
    Evaluation of the prognostic value of all four HER family receptors in patients with metastatic breast cancer treated with trastuzumab: A Hellenic Cooperative Oncology Group (HeCOG) study.
    PLoS One. 2018;13:e0207707.
    PubMed     Abstract available

  461. BOU-DARGHAM MJ, Liu Y, Sang QA, Zhang J, et al
    Subgrouping breast cancer patients based on immune evasion mechanisms unravels a high involvement of transforming growth factor-beta and decoy receptor 3.
    PLoS One. 2018;13:e0207799.
    PubMed     Abstract available

  462. MADDEN JM, Duffy MJ, Zgaga L, Bennett K, et al
    Trends in vitamin D supplement use in a general female and breast cancer population in Ireland: A repeated cross-sectional study.
    PLoS One. 2018;13:e0209033.
    PubMed     Abstract available

  463. CINGIR KOKER S, Jahja E, Shehwana H, Keskus AG, et al
    Cholinergic Receptor Nicotinic Alpha 5 (CHRNA5) RNAi is associated with cell cycle inhibition, apoptosis, DNA damage response and drug sensitivity in breast cancer.
    PLoS One. 2018;13:e0208982.
    PubMed     Abstract available

  464. BANG JI, Yoon HJ, Kim BS
    Clinical utility of FDG uptake within reticuloendothelial system on F-18 FDG PET/CT for prediction of tumor recurrence in breast cancer.
    PLoS One. 2018;13:e0208861.
    PubMed     Abstract available

  465. DE MEULENAERE V, Neyt S, Vandeghinste B, Mollet P, et al
    Species-dependent extracranial manifestations of a brain seeking breast cancer cell line.
    PLoS One. 2018;13:e0208340.
    PubMed     Abstract available

  466. WALKER AK, Chang A, Ziegler AI, Dhillon HM, et al
    Low dose aspirin blocks breast cancer-induced cognitive impairment in mice.
    PLoS One. 2018;13:e0208593.
    PubMed     Abstract available

  467. QIU L, Levine K, Gajiwala KS, Cronin CN, et al
    Small molecule inhibitors reveal PTK6 kinase is not an oncogenic driver in breast cancers.
    PLoS One. 2018;13:e0198374.
    PubMed     Abstract available

  468. PRAGER M, Kiechle M, Stollenwerk B, Hinzen C, et al
    Costs and effects of intra-operative fluorescence molecular imaging - A model-based, early assessment.
    PLoS One. 2018;13:e0198137.
    PubMed     Abstract available

  469. MYUNG Y, Son Y, Nam TH, Kang E, et al
    Objective assessment of flap volume changes and aesthetic results after adjuvant radiation therapy in patients undergoing immediate autologous breast reconstruction.
    PLoS One. 2018;13:e0197615.
    PubMed     Abstract available

  470. SRIMUNINNIMIT V, Pornpraserthsuk P, Chaiwerawattana A, Kongdan Y, et al
    Real-life clinical pattern, management, and survival in Thai patients with early-stage or metastatic triple-negative breast cancer.
    PLoS One. 2018;13:e0209040.
    PubMed     Abstract available

  471. CHEN FP, Chien MH, Chen HY, Ng YT, et al
    Effects of phthalates on normal human breast cells co-cultured with different fibroblasts.
    PLoS One. 2018;13:e0199596.
    PubMed     Abstract available

  472. HAHN EC, Bittar CM, Vianna FSL, Netto CBO, et al
    TP53 p.Arg337His germline mutation prevalence in Southern Brazil: Further evidence for mutation testing in young breast cancer patients.
    PLoS One. 2018;13:e0209934.
    PubMed     Abstract available

  473. BERTAUT A, Coudert J, Bengrine L, Dancourt V, et al
    Does mammogram attendance influence participation in cervical and colorectal cancer screening? A prospective study among 1856 French women.
    PLoS One. 2018;13:e0198939.
    PubMed     Abstract available

  474. TEA MM, Tan YY, Staudigl C, Eibl B, et al
    Improving comprehension of genetic counseling for hereditary breast and ovarian cancer clients with a visual tool.
    PLoS One. 2018;13:e0200559.
    PubMed     Abstract available

  475. ONISHI H, Udagawa C, Kubo M, Nakamura S, et al
    A genome-wide association study identifies three novel genetic markers for response to tamoxifen: A prospective multicenter study.
    PLoS One. 2018;13:e0201606.
    PubMed     Abstract available

  476. HONG JH, Ko YH, Kang K
    RNA variant identification discrepancy among splice-aware alignment algorithms.
    PLoS One. 2018;13:e0201822.
    PubMed     Abstract available

  477. BISWENGER V, Baumann N, Jurschick J, Hackl M, et al
    Characterization of EGF-guided MDA-MB-231 cell chemotaxis in vitro using a physiological and highly sensitive assay system.
    PLoS One. 2018;13:e0203040.
    PubMed     Abstract available

  478. NAGORSKI J, Allen GI
    Genomic region detection via Spatial Convex Clustering.
    PLoS One. 2018;13:e0203007.
    PubMed     Abstract available

  479. JOSE V, Fumagalli D, Rothe F, Majjaj S, et al
    Feasibility of developing reliable gene expression modules from FFPE derived RNA profiled on Affymetrix arrays.
    PLoS One. 2018;13:e0203346.
    PubMed     Abstract available

  480. XIE L, Sun Z, Hong Z, Brown NJ, et al
    Temporal and molecular dynamics of human metastatic breast carcinoma cell adhesive interactions with human bone marrow endothelium analyzed by single-cell force spectroscopy.
    PLoS One. 2018;13:e0204418.
    PubMed     Abstract available

  481. JUNG H, Kim B, Lee I, Yoo M, et al
    Detection of masses in mammograms using a one-stage object detector based on a deep convolutional neural network.
    PLoS One. 2018;13:e0203355.
    PubMed     Abstract available

  482. SERGANOVA I, Cohen IJ, Vemuri K, Shindo M, et al
    LDH-A regulates the tumor microenvironment via HIF-signaling and modulates the immune response.
    PLoS One. 2018;13:e0203965.
    PubMed     Abstract available

  483. OU J, Si Y, Goh K, Yasui N, et al
    Bioprocess development of antibody-drug conjugate production for cancer treatment.
    PLoS One. 2018;13:e0206246.
    PubMed     Abstract available

  484. ALKARAKOOLY Z, Al-Anbaky QA, Kannan K, Ali N, et al
    Metabolic reprogramming by Dichloroacetic acid potentiates photodynamic therapy of human breast adenocarcinoma MCF-7 cells.
    PLoS One. 2018;13:e0206182.
    PubMed     Abstract available

  485. JINESH GG, Flores ER, Brohl AS
    Chromosome 19 miRNA cluster and CEBPB expression specifically mark and potentially drive triple negative breast cancers.
    PLoS One. 2018;13:e0206008.
    PubMed     Abstract available

  486. JOO MW, Kang YK, Ogura K, Iwata S, et al
    Post-radiation sarcoma: A study by the Eastern Asian Musculoskeletal Oncology Group.
    PLoS One. 2018;13:e0204927.
    PubMed     Abstract available

  487. DHAGE S, Ernlund A, Ruggles K, Axelrod D, et al
    A genomic ruler to assess oncogenic transition between breast tumor and stroma.
    PLoS One. 2018;13:e0205602.
    PubMed     Abstract available

  488. KUMAR V, Denis M, Gregory A, Bayat M, et al
    Viscoelastic parameters as discriminators of breast masses: Initial human study results.
    PLoS One. 2018;13:e0205717.
    PubMed     Abstract available

  489. COTTU PH, Bonneterre J, Varga A, Campone M, et al
    Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers.
    PLoS One. 2018;13:e0204973.
    PubMed     Abstract available

  490. STARLARD-DAVENPORT A, Allman R, Dite GS, Hopper JL, et al
    Validation of a genetic risk score for Arkansas women of color.
    PLoS One. 2018;13:e0204834.
    PubMed     Abstract available

  491. WANG K, Duan X, Gao F, Wang W, et al
    Dissecting cancer heterogeneity based on dimension reduction of transcriptomic profiles using extreme learning machines.
    PLoS One. 2018;13:e0203824.
    PubMed     Abstract available

  492. BURTON LJ, Hawsawi O, Loyd Q, Henderson V, et al
    Association of Epithelial Mesenchymal Transition with prostate and breast health disparities.
    PLoS One. 2018;13:e0203855.
    PubMed     Abstract available

  493. VILLANUEVA PJ, Martinez A, Baca ST, DeJesus RE, et al
    Pyronaridine exerts potent cytotoxicity on human breast and hematological cancer cells through induction of apoptosis.
    PLoS One. 2018;13:e0206467.
    PubMed     Abstract available

  494. CHIANG YS, Huang YF, Midha MK, Chen TH, et al
    Single cell transcriptome analysis of MCF-7 reveals consistently and inconsistently expressed gene groups each associated with distinct cellular localization and functions.
    PLoS One. 2018;13:e0199471.
    PubMed     Abstract available

  495. LIN ZP, Zhu YL, Lo YC, Moscarelli J, et al
    Combination of triapine, olaparib, and cediranib suppresses progression of BRCA-wild type and PARP inhibitor-resistant epithelial ovarian cancer.
    PLoS One. 2018;13:e0207399.
    PubMed     Abstract available

  496. HUANG MH, Blackwood J, Godoshian M, Pfalzer L, et al
    Factors associated with self-reported falls, balance or walking difficulty in older survivors of breast, colorectal, lung, or prostate cancer: Results from Surveillance, Epidemiology, and End Results-Medicare Health Outcomes Survey linkage.
    PLoS One. 2018;13:e0208573.
    PubMed     Abstract available

    January 2017
  497. SU S, Bao H, Wang X, Wang Z, et al
    The quality of invasive breast cancer care for low reimbursement rate patients: A retrospective study.
    PLoS One. 2017;12:e0184866.
    PubMed     Abstract available

  498. ZEIDAN AM, Long JB, Wang R, Hu X, et al
    Risk of myeloid neoplasms after radiotherapy among older women with localized breast cancer: A population-based study.
    PLoS One. 2017;12:e0184747.
    PubMed     Abstract available

  499. LEFTIN A, Ben-Chetrit N, Klemm F, Joyce JA, et al
    Iron imaging reveals tumor and metastasis macrophage hemosiderin deposits in breast cancer.
    PLoS One. 2017;12:e0184765.
    PubMed     Abstract available

  500. FUKADA I, Ito Y, Kobayashi K, Shibayama T, et al
    The early onset of peripheral neuropathy might be a robust predictor for time to treatment failure in patients with metastatic breast cancer receiving chemotherapy containing paclitaxel.
    PLoS One. 2017;12:e0184322.
    PubMed     Abstract available

  501. LU S, Qian Y, Huang X, Yu H, et al
    The association of dietary pattern and breast cancer in Jiangsu, China: A population-based case-control study.
    PLoS One. 2017;12:e0184453.
    PubMed     Abstract available

  502. POPOLIN CP, Reis JPB, Becceneri AB, Graminha AE, et al
    Cytotoxicity and anti-tumor effects of new ruthenium complexes on triple negative breast cancer cells.
    PLoS One. 2017;12:e0183275.
    PubMed     Abstract available

  503. GOTZ TI, Lahmer G, Strnad V, Bert C, et al
    A tool to automatically analyze electromagnetic tracking data from high dose rate brachytherapy of breast cancer patients.
    PLoS One. 2017;12:e0183608.
    PubMed     Abstract available

  504. PARK NJ, Chang Y, Bender C, Conley Y, et al
    Cardiovascular disease and mortality after breast cancer in postmenopausal women: Results from the Women's Health Initiative.
    PLoS One. 2017;12:e0184174.
    PubMed     Abstract available

  505. BUONOMO OC, Caredda E, Portarena I, Vanni G, et al
    New insights into the metastatic behavior after breast cancer surgery, according to well-established clinicopathological variables and molecular subtypes.
    PLoS One. 2017;12:e0184680.
    PubMed     Abstract available

  506. PADALA C, Tupurani MA, Puranam K, Gantala S, et al
    Synergistic effect of collagenase-1 (MMP1), stromelysin-1 (MMP3) and gelatinase-B (MMP9) gene polymorphisms in breast cancer.
    PLoS One. 2017;12:e0184448.
    PubMed     Abstract available

  507. FUJII T, Reuben JM, Huo L, Espinosa Fernandez JR, et al
    Androgen receptor expression on circulating tumor cells in metastatic breast cancer.
    PLoS One. 2017;12:e0185231.
    PubMed     Abstract available

  508. LAMPA M, Arlt H, He T, Ospina B, et al
    Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition.
    PLoS One. 2017;12:e0185092.
    PubMed     Abstract available

  509. SCHMITZ AMT, Veldhuis WB, Menke-Pluijmers MBE, van der Kemp WJM, et al
    Preoperative indication for systemic therapy extended to patients with early-stage breast cancer using multiparametric 7-tesla breast MRI.
    PLoS One. 2017;12:e0183855.
    PubMed     Abstract available

  510. GSCHWANTLER-KAULICH D, Weingartshofer S, Grunt TW, Mairhofer M, et al
    Estradiol impairs the antiproliferative and proapoptotic effect of Zoledronic acid in hormone sensitive breast cancer cells in vitro.
    PLoS One. 2017;12:e0185566.
    PubMed     Abstract available

  511. SUCHANSKI J, Tejchman A, Zacharski M, Piotrowska A, et al
    Podoplanin increases the migration of human fibroblasts and affects the endothelial cell network formation: A possible role for cancer-associated fibroblasts in breast cancer progression.
    PLoS One. 2017;12:e0184970.
    PubMed     Abstract available

  512. ZHANG W, Wang W, Chai W, Luo X, et al
    Breast tissue ablation with irreversible electroporation in rabbits: A safety and feasibility study.
    PLoS One. 2017;12:e0181555.
    PubMed     Abstract available

  513. DI NAPOLI A, Pepe G, Giarnieri E, Cippitelli C, et al
    Cytological diagnostic features of late breast implant seromas: From reactive to anaplastic large cell lymphoma.
    PLoS One. 2017;12:e0181097.
    PubMed     Abstract available

  514. SANO H, Goto R, Hamashima C
    Does lack of resources impair access to breast and cervical cancer screening in Japan?
    PLoS One. 2017;12:e0180819.
    PubMed     Abstract available

  515. KIRCHNER J, Sawicki LM, Deuschl C, Gruneisen J, et al
    18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine.
    PLoS One. 2017;12:e0180349.
    PubMed     Abstract available

  516. MARQUEZ-RODAS I, Pollan M, Escudero MJ, Ruiz A, et al
    Frequency of breast cancer with hereditary risk features in Spain: Analysis from GEICAM "El Alamo III" retrospective study.
    PLoS One. 2017;12:e0184181.
    PubMed     Abstract available

  517. CILEK EE, Ozturk H, Gur Dedeoglu B
    Construction of miRNA-miRNA networks revealing the complexity of miRNA-mediated mechanisms in trastuzumab treated breast cancer cell lines.
    PLoS One. 2017;12:e0185558.
    PubMed     Abstract available

  518. AUKES K, Forsman C, Brady NJ, Astleford K, et al
    Breast cancer cell-derived fibroblast growth factors enhance osteoclast activity and contribute to the formation of metastatic lesions.
    PLoS One. 2017;12:e0185736.
    PubMed     Abstract available

  519. KORKOLA JE, Collisson EA, Heiser LM, Oates C, et al
    Correction: Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast Cancer.
    PLoS One. 2017;12:e0186551.
    PubMed     Abstract available

  520. QIAO W, Jia Z, Liu H, Liu Q, et al
    Prognostic and clinicopathological value of Twist expression in breast cancer: A meta-analysis.
    PLoS One. 2017;12:e0186191.
    PubMed     Abstract available

  521. XIE F, Hosany S, Zhong S, Jiang Y, et al
    MicroRNA-193a inhibits breast cancer proliferation and metastasis by downregulating WT1.
    PLoS One. 2017;12:e0185565.
    PubMed     Abstract available

  522. THIRUNAVUKKARASAN M, Wang C, Rao A, Hind T, et al
    Short-chain fatty acid receptors inhibit invasive phenotypes in breast cancer cells.
    PLoS One. 2017;12:e0186334.
    PubMed     Abstract available

  523. MAHAJAN AS, Sugita BM, Duttargi AN, Saenz F, et al
    Genomic comparison of early-passage conditionally reprogrammed breast cancer cells to their corresponding primary tumors.
    PLoS One. 2017;12:e0186190.
    PubMed     Abstract available

  524. RAZAZAN A, Behravan J, Arab A, Barati N, et al
    Conjugated nanoliposome with the HER2/neu-derived peptide GP2 as an effective vaccine against breast cancer in mice xenograft model.
    PLoS One. 2017;12:e0185099.
    PubMed     Abstract available

  525. HEQUET D, Callens C, Gentien D, Albaud B, et al
    Prospective, multicenter French study evaluating the clinical impact of the Breast Cancer Intrinsic Subtype-Prosigna(R) Test in the management of early-stage breast cancers.
    PLoS One. 2017;12:e0185753.
    PubMed     Abstract available

  526. PEARCE A, Haas M, Viney R, Pearson SA, et al
    Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study.
    PLoS One. 2017;12:e0184360.
    PubMed     Abstract available

  527. VALIANATOS G, Valcikova B, Growkova K, Verlande A, et al
    A small molecule drug promoting miRNA processing induces alternative splicing of MdmX transcript and rescues p53 activity in human cancer cells overexpressing MdmX protein.
    PLoS One. 2017;12:e0185801.
    PubMed     Abstract available

  528. HEBBRECHT T, Van Audenhove I, Zwaenepoel O, Verhelle A, et al
    VCA nanobodies target N-WASp to reduce invadopodium formation and functioning.
    PLoS One. 2017;12:e0185076.
    PubMed     Abstract available

  529. NISHIMUKAI A, Inoue N, Kira A, Takeda M, et al
    Tumor size and proliferative marker geminin rather than Ki67 expression levels significantly associated with maximum uptake of 18F-deoxyglucose levels on positron emission tomography for breast cancers.
    PLoS One. 2017;12:e0184508.
    PubMed     Abstract available

  530. SERRANO-GOMEZ SJ, Sanabria-Salas MC, Garay J, Baddoo MC, et al
    Ancestry as a potential modifier of gene expression in breast tumors from Colombian women.
    PLoS One. 2017;12:e0183179.
    PubMed     Abstract available

  531. DIMITROPOULOS K, Barmpoutis P, Zioga C, Kamas A, et al
    Grading of invasive breast carcinoma through Grassmannian VLAD encoding.
    PLoS One. 2017;12:e0185110.
    PubMed     Abstract available

  532. KANG HJ, Kim SW, Son SH
    The feasibility of a heart block with an electron compensation as an alternative whole breast radiotherapy technique in patients with underlying cardiac or pulmonary disease.
    PLoS One. 2017;12:e0184137.
    PubMed     Abstract available

  533. CHEN Z, Yang J, Li S, Lv M, et al
    Invasive lobular carcinoma of the breast: A special histological type compared with invasive ductal carcinoma.
    PLoS One. 2017;12:e0182397.
    PubMed     Abstract available

  534. PARK JM, Bae SJ, Yoon C, Lee HS, et al
    Comparison of patients with small (</=2 cm) breast cancer according to adherence to breast screening program.
    PLoS One. 2017;12:e0186988.
    PubMed     Abstract available

  535. LAI HW, Liu LC, Ouyang F, Yao CC, et al
    Multi-center study on patient selection for and the oncologic safety of intraoperative radiotherapy (IORT) with the Xoft Axxent(R) eBx(R) System for the management of early stage breast cancer in Taiwan.
    PLoS One. 2017;12:e0185876.
    PubMed     Abstract available

  536. HENLE AM, Nassar A, Puglisi-Knutson D, Youssef B, et al
    Downregulation of TAP1 and TAP2 in early stage breast cancer.
    PLoS One. 2017;12:e0187323.
    PubMed     Abstract available

  537. COIGNET MV, Zirpoli GR, Roberts MR, Khoury T, et al
    Genetic variations, reproductive aging, and breast cancer risk in African American and European American women: The Women's Circle of Health Study.
    PLoS One. 2017;12:e0187205.
    PubMed     Abstract available

  538. JOHANNESSEN C, Moi L, Kiselev Y, Pedersen MI, et al
    Expression and function of the miR-143/145 cluster in vitro and in vivo in human breast cancer.
    PLoS One. 2017;12:e0186658.
    PubMed     Abstract available

  539. REESE DE, Henderson MC, Silver M, Mulpuri R, et al
    Breast density does not impact the ability of Videssa(R) Breast to detect breast cancer in women under age 50.
    PLoS One. 2017;12:e0186198.
    PubMed     Abstract available

  540. SUNG PL, Wen KC, Chen YJ, Chao TC, et al
    The frequency of cancer predisposition gene mutations in hereditary breast and ovarian cancer patients in Taiwan: From BRCA1/2 to multi-gene panels.
    PLoS One. 2017;12:e0185615.
    PubMed     Abstract available

  541. LAROCHE F, Perrot S, Medkour T, Cottu PH, et al
    Quality of life and impact of pain in women treated with aromatase inhibitors for breast cancer. A multicenter cohort study.
    PLoS One. 2017;12:e0187165.
    PubMed     Abstract available

  542. WAKAI R, Ishitsuka M, Kishimoto T, Ochiai T, et al
    Identification of genes and critical control proteins associated with inflammatory breast cancer using network controllability.
    PLoS One. 2017;12:e0186353.
    PubMed     Abstract available

  543. THERIAU CF, Sauve OS, Beaudoin MS, Wright DC, et al
    Proliferative endocrine effects of adipose tissue from obese animals on MCF7 cells are ameliorated by resveratrol supplementation.
    PLoS One. 2017;12:e0183897.
    PubMed     Abstract available

  544. HIRONAKA-MITSUHASHI A, Matsuzaki J, Takahashi RU, Yoshida M, et al
    A tissue microRNA signature that predicts the prognosis of breast cancer in young women.
    PLoS One. 2017;12:e0187638.
    PubMed     Abstract available

  545. SYED S, Schober J, Blanco A, Zustiak SP, et al
    Morphological adaptations in breast cancer cells as a function of prolonged passaging on compliant substrates.
    PLoS One. 2017;12:e0187853.
    PubMed     Abstract available

  546. CARLSEN JF, Ewertsen C, Sletting S, Talman ML, et al
    Strain histograms are equal to strain ratios in predicting malignancy in breast tumours.
    PLoS One. 2017;12:e0186230.
    PubMed     Abstract available

  547. KYEONG S, Cha YJ, Ahn SG, Suh SH, et al
    Subtypes of breast cancer show different spatial distributions of brain metastases.
    PLoS One. 2017;12:e0188542.
    PubMed     Abstract available

  548. THOMPSON KJ, Ingle JN, Tang X, Chia N, et al
    A comprehensive analysis of breast cancer microbiota and host gene expression.
    PLoS One. 2017;12:e0188873.
    PubMed     Abstract available

  549. MARINHO EDC, Custodio IDD, Ferreira IB, Crispim CA, et al
    Impact of chemotherapy on perceptions related to food intake in women with breast cancer: A prospective study.
    PLoS One. 2017;12:e0187573.
    PubMed     Abstract available

  550. AZIZI M, Ghourchian H, Yazdian F, Dashtestani F, et al
    Cytotoxic effect of albumin coated copper nanoparticle on human breast cancer cells of MDA-MB 231.
    PLoS One. 2017;12:e0188639.
    PubMed     Abstract available

  551. MAYORAL-VARO V, Calcabrini A, Sanchez-Bailon MP, Martin-Perez J, et al
    miR205 inhibits stem cell renewal in SUM159PT breast cancer cells.
    PLoS One. 2017;12:e0188637.
    PubMed     Abstract available

  552. ARENAS M, Garcia-Heredia A, Cabre N, Luciano-Mateo F, et al
    Effect of radiotherapy on activity and concentration of serum paraoxonase-1 in breast cancer patients.
    PLoS One. 2017;12:e0188633.
    PubMed     Abstract available

  553. AHN SG, Bae SJ, Yoon C, Cha YJ, et al
    Chemosensitivity to doxorubicin of ER-positive/HER2-negative breast cancers with high 21-gene recurrence score: A study based on in vitro chemoresponse assay.
    PLoS One. 2017;12:e0187679.
    PubMed     Abstract available

  554. ZEUNE L, van Dalum G, Decraene C, Proudhon C, et al
    Quantifying HER-2 expression on circulating tumor cells by ACCEPT.
    PLoS One. 2017;12:e0186562.
    PubMed     Abstract available

  555. TAKEUCHI H, Abe M, Takumi Y, Hashimoto T, et al
    The prognostic impact of the platelet distribution width-to-platelet count ratio in patients with breast cancer.
    PLoS One. 2017;12:e0189166.
    PubMed     Abstract available

  556. KASANGIAN AA, Gherardi G, Biagioli E, Torri V, et al
    The prognostic role of tumor size in early breast cancer in the era of molecular biology.
    PLoS One. 2017;12:e0189127.
    PubMed     Abstract available

  557. AGARWAL S, Ying J, Boucher KM, Agarwal JP, et al
    The association between socioeconomic factors and breast cancer-specific survival varies by race.
    PLoS One. 2017;12:e0187018.
    PubMed     Abstract available

  558. DAVIES G, Lobanova L, Dawicki W, Groot G, et al
    Metformin inhibits the development, and promotes the resensitization, of treatment-resistant breast cancer.
    PLoS One. 2017;12:e0187191.
    PubMed     Abstract available

  559. ZHANG H, Diao H, Jia L, Yuan Y, et al
    Proteus mirabilis inhibits cancer growth and pulmonary metastasis in a mouse breast cancer model.
    PLoS One. 2017;12:e0188960.
    PubMed     Abstract available

  560. ALEMAR B, Gregorio C, Herzog J, Matzenbacher Bittar C, et al
    BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population?
    PLoS One. 2017;12:e0187630.
    PubMed     Abstract available

  561. KIM GE, Lee JS, Park MH, Yoon JH, et al
    Epithelial periostin expression is correlated with poor survival in patients with invasive breast carcinoma.
    PLoS One. 2017;12:e0187635.
    PubMed     Abstract available

  562. HENDERSON HJ, Karanam B, Samant R, Vig K, et al
    Neuroligin 4X overexpression in human breast cancer is associated with poor relapse-free survival.
    PLoS One. 2017;12:e0189662.
    PubMed     Abstract available

  563. ZEINOMAR N, Thai A, Cloud AJ, McDonald JA, et al
    Alcohol consumption and breast cancer-specific and all-cause mortality in women diagnosed with breast cancer at the New York site of the Breast Cancer Family Registry.
    PLoS One. 2017;12:e0189118.
    PubMed     Abstract available

  564. SYED BM, Morgan D, Setty T, Green AR, et al
    Oestrogen receptor negative early operable primary breast cancer in older women-Biological characteristics and long-term clinical outcome.
    PLoS One. 2017;12:e0188528.
    PubMed     Abstract available

  565. FATIMA I, El-Ayachi I, Taotao L, Lillo MA, et al
    The natural compound Jatrophone interferes with Wnt/beta-catenin signaling and inhibits proliferation and EMT in human triple-negative breast cancer.
    PLoS One. 2017;12:e0189864.
    PubMed     Abstract available

  566. SOBRAL-LEITE M, Lips EH, Vieira-Monteiro HA, Giacomin LC, et al
    Evaluation of the EGFR polymorphism R497K in two cohorts of neoadjuvantly treated breast cancer patients.
    PLoS One. 2017;12:e0189750.
    PubMed     Abstract available

  567. DABI Y, Darrigues L, Pons K, Mabille M, et al
    Incidence of inflammatory breast cancer in patients with clinical inflammatory breast symptoms.
    PLoS One. 2017;12:e0189385.
    PubMed     Abstract available

  568. LIU CY, Lau KY, Hsu CC, Chen JL, et al
    Combination of palbociclib with enzalutamide shows in vitro activity in RB proficient and androgen receptor positive triple negative breast cancer cells.
    PLoS One. 2017;12:e0189007.
    PubMed     Abstract available

  569. RUMNEY RMH, Coffelt SB, Neale TA, Dhayade S, et al
    PyMT-Maclow: A novel, inducible, murine model for determining the role of CD68 positive cells in breast tumor development.
    PLoS One. 2017;12:e0188591.
    PubMed     Abstract available

  570. FIOCCHETTI M, Cipolletti M, Marino M
    Compensatory role of Neuroglobin in nervous and non-nervous cancer cells in response to the nutrient deprivation.
    PLoS One. 2017;12:e0189179.
    PubMed     Abstract available

  571. CATTANEO ER, Prieto ED, Garcia-Fabiani MB, Montanaro MA, et al
    Glycerol-3-phosphate acyltransferase 2 expression modulates cell roughness and membrane permeability: An atomic force microscopy study.
    PLoS One. 2017;12:e0189031.
    PubMed     Abstract available

  572. CARNESECCHI J, Cerutti C, Vanacker JM, Forcet C, et al
    ERRalpha protein is stabilized by LSD1 in a demethylation-independent manner.
    PLoS One. 2017;12:e0188871.
    PubMed     Abstract available

  573. BENNANI-BAITI B, Dietzel M, Baltzer PA
    MRI for the assessment of malignancy in BI-RADS 4 mammographic microcalcifications.
    PLoS One. 2017;12:e0188679.
    PubMed     Abstract available

  574. DENIZ S, Kurt B, Oguzoncul AF, Nazlican E, et al
    Knowledge, attitudes and behaviours of women regarding breast and cervical cancer in Malatya, Turkey.
    PLoS One. 2017;12:e0188571.
    PubMed     Abstract available

  575. ORTIZ AB, Garcia D, Vicente Y, Palka M, et al
    Prognostic significance of cyclin D1 protein expression and gene amplification in invasive breast carcinoma.
    PLoS One. 2017;12:e0188068.
    PubMed     Abstract available

  576. JIN D, Lee H
    FGMD: A novel approach for functional gene module detection in cancer.
    PLoS One. 2017;12:e0188900.
    PubMed     Abstract available

  577. PAUL B, Royston KJ, Li Y, Stoll ML, et al
    Impact of genistein on the gut microbiome of humanized mice and its role in breast tumor inhibition.
    PLoS One. 2017;12:e0189756.
    PubMed     Abstract available

  578. HANLEY JA, Hannigan A, O'Brien KM
    Mortality reductions due to mammography screening: Contemporary population-based data.
    PLoS One. 2017;12:e0188947.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.